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Abstract 
Heat shock proteins (HSPs) are molecular chaperones that assist in protein synthesis, folding 
and degradation and prevent stress-induced protein aggregation. The present study examined 
the pattern of accumulation of HSP30 and HSP70 in cells recovering from heat shock as well 
as the effect of proteasome inhibition on cytoplasmic/nuclear and endoplasmic reticulum 
(ER) molecular chaperone accumulation, large multimeric HSP30 complexes, stress granule 
and aggresome formation in Xenopus laevis A6 kidney epithelial cells. Initial immunoblot 
analysis revealed the presence of elevated levels of HSP30 after 72 h of recovery. However, 
the relative levels of HSP70 declined to near control levels after 24 h. The relative levels of 
both hsp30 and hsp70 mRNA were reduced to low levels after 24 h of recovery from heat 
shock. Pretreatment of cells with cycloheximide, a translational inhibitor, produced a rapid 
decline in HSP70 but not HSP30. The cycloheximide-associated decline of HSP70 was 
blocked by the proteasomal inhibitor, MG132, but had little effect on the relative level of 
HSP30. Also, treatment of cells with the phosphorylation inhibitor, SB203580, in addition to 
cycloheximide treatment enhanced the stability of HSP30 compared to cycloheximide alone. 
Immunocytochemical studies detected the presence of HSP30 accumulation in a granular 
pattern in the cytoplasm of recovering cells and its association with aggresome-like 
structures, which was enhanced in the presence of SB203580. To verify if proteasome 
inhibition in A6 cells induced the formation of similar HSP30 granules, immunoblot and 
immunocytochemical analyses were performed. MG132, celastrol and withaferin A enhanced 
ubiquitinated proteins, inhibited chymotrypsin-like activity of the proteasome and induced 
the accumulation of cytoplasmic/nuclear HSPs, HSP30 and HSP70 as well as ER chaperones, 
BiP and GRP94 and heme oxygenase-1. Northern blot experiments determined that 
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proteasome inhibitors induced an accumulation in hsp30, hsp70 and bip mRNA but not 
eIF1α. The final part of this study demonstrated that treatment of A6 cells with proteasome 
inhibitors or sodium arsenite or cadmium chloride induced HSP30 multimeric complex 
formation primarily in the cytoplasm. Moreover, these stressors also induced the formation of 
RNA stress granules, pre-stalled translational complexes, which were detected via TIA1 and 
polyA binding protein (PABP), which are known stress granule markers. These stress 
granules, however, did not co-localize with large HSP30 multimeric complexes. In 
comparison, proteasome inhibition or treatment with sodium arsenite or cadmium chloride 
also induced the formation of aggresome-like structures, which are proteinaceous inclusion 
bodies formed as a result of an abundance of aggregated protein. Aggresome formation was 
identified by monitoring the presence of vimentin and γ-tubulin, both of which are 
cytoskeletal proteins and serve as markers of aggresome detection. Aggresome formation, 
which was also verified using the ProteoStat assay, co-localized with large HSP30 
multimeric complexes. Co-immunoprecipitation experiments revealed that HSP30 associated 
with γ-tubulin and β-actin in cells treated with proteasome inhibitors or sodium arsenite or 
cadmium chloride suggesting a possible role in aggresome formation. In conclusion, this 
study has shown that the relative levels of heat shock-induced HSP30 persist during recovery 
in contrast to HSP70. While HSP70 is degraded by the ubiquitin-proteasome system, it is 
likely that the presence of HSP30 multimeric complexes that are known to associate with 
unfolded protein as well as its association with aggresome-like structures may delay its 
degradation. Finally, proteasome inhibition, sodium arsenite and cadmium chloride treatment 
of A6 cells induced cytoplasmic/nuclear and ER chaperones as well as resulting in the 
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formation stress granules and aggresome-like structures which associated with large HSP30 
multimeric complexes. 
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Chapter 1: Introduction 
1.1 Introduction 
Organisms have evolved stress-responsive intracellular networks that can identify, 
monitor and respond to stressful stimuli (Morimoto, 2008). At the molecular level, 
environmental and physiological stressors can disrupt protein function and stability causing 
proteins to unfold or misfold into non-native conformations (Morimoto, 1998; Balch et al., 
2008). Polypeptides that are abnormally folded are prone to cytotoxic aggregation, which can 
result in aberrant cellular processes and/or disease (Morimoto, 2008). As a result, molecular 
chaperone systems, such as heat shock proteins (HSPs), have evolved to assist in the 
refolding of unfolded/misfolded proteins and inhibit the formation of cytotoxic protein 
aggregates. 
 
1.2 Heat shock proteins 
HSPs are molecular chaperones that are involved in many cellular processes 
including protein synthesis, folding and assembly, membrane translocation and degradation. 
HSPs also bind to denatured proteins and assist in their refolding to their native state or target 
them for degradation in order to prevent stress-induced protein aggregation. HSPs have been 
well documented in a wide variety of organisms (Katschinski, 2004). There are at least 6 
different HSP families that have been characterized to date including small HSPs (sHSPs), 
HSP40, HSP60, HSP70, HSP90 and HSP100 (Katschinski, 2004; Morimoto, 2008). Hsp 
gene expression patterns vary between organisms, tissues types, and developmental stages 
(Lindquist, 1986; Heikkila et al., 1997). Some hsp genes are expressed constitutively while 
others are stress-inducible (Katschinski, 2004).  
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1.2.1 Small heat shock proteins (sHSPs) 
The sHSPs (16 – 42 kDa) are an evolutionarily divergent superfamily of proteins with 
the exception of an 80-100 amino acid conserved α-crystallin domain (MacRae, 2000; Van 
Montfort et al., 2001). The number, size and sequence of the family members vary between 
species (Arrigo and Landry, 1994; Stromer et al., 2003). The major sHSP families include 
HSP27 and the -crystallins. Despite their lack of conservation, most sHSPs usually have 
three functional domains. These regions include the conserved α-crystallin domain, an 
amino-terminal extension and a carboxy-terminal extension. The secondary structure of the 
α-crystallin domain consists of β-strands organized into β-sheets that are required for dimer 
formation, the basic functional units of sHSP complexes (Buchner et al., 1998; MacRae, 
2000). The N-terminal extension is poorly conserved except for the Trp-Asp-Pro-Phe 
(WDPF) sequence, which may play a role in oligomer formation (Lambert et al., 1999; 
Ganea, 2001). The C-terminal extension, which is poorly conserved and variable in length, 
was shown to be essential for stabilization of the quaternary structure, solubility and 
chaperone activity (MacRae, 2000; Fernando and Heikkila, 2000; Morris et al., 2008). 
SHSPs have the ability to form highly polymeric structures that are necessary for 
their chaperone functions in vivo (Sun and MacRae, 2005; Hilario et al., 2011). Various 
functions that have been suggested for sHSPs include resistance against apoptosis, 
acquisition of thermotolerance, actin capping/decapping activity and cellular differentiation 
(Arrigo, 1998; MacRae, 2000; Van Montfort et al., 2001; Heikkila, 2010). As a result, the 
role of sHSPs in several medical conditions such as multiple sclerosis, cardiovascular 
diseases, oncogenesis and neurodegenerative diseases have been investigated (Jolly and 
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Morimoto, 2000; Westerheide and Morimoto, 2005; Ghayour-Mobarhan et al., 2012; 
Vidyasagar et al., 2012). 
Another small HSP is HSP32. However, HSP32 is not a member of the sHSP 
superfamily since it was discovered to be heme oxygenase-1, an oxidative stress-inducible 
enzyme that catalyzes the breakdown of heme into bilirubin, iron and carbon monoxide 
(Keyse and Tyrrell, 1989; Elbirt et al., 1998). The ho-1 gene is expressed primarily in the 
spleen, where senescent erythrocytes are sequestered and hemoglobin is degraded, as well as 
in kidney and liver (Raju et al., 1997). HO-1 accumulation was induced by agents that cause 
oxidative stress including sodium arsenite, UV radiation, hyperoxia, glutathione depletion 
and proteasomal inhibition (Keyse and Tyrrell, 1989; Elbirt et al., 1998; Oguro et al., 1998, 
Otterbein et al., 1999). More specifically, the ho-1 gene is induced via the nuclear factor-like 
2 (Nrf2) pathway, which can be activated by many compounds including proteasome 
inhibitors such as bortezomib, curcumin or MG132 as well as heavy metals like sodium 
arsenite and cadmium (Alam et al., 2000; Wu et al., 2004; Yamamoto et al., 2010; Kastle et 
al., 2012; Wang et al., 2013; Furfaro et al., 2014). Heat shock also induced HO-1 expression 
in various rat organs, European sea bass liver, mouse Sertoli cells, human fibroblasts and 
hepatoma cells (Taketani et al., 1988; Keyse and Tyrrell, 1989; Mitani et al., 1990; Raju and 
Maines, 1994; Lee et al., 1996; Hachfi et al., 2012; Li et al., 2014). However, heat shock did 
not enhance HO-1 accumulation in human alveolar macrophages, fibroblasts, hepatoma, 
glioma, HeLa, or HL60 cells (Yoshida et al., 1988; Keyse and Tyrrell, 1989; Taketani et al., 
1989; Mitani et al., 1990; Okinaga et al., 1996).  
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1.2.1.1 HSP27 
HSP27, also known as HSPB1, is the most extensively studied sHSP and is present in 
a variety of organisms. HSP27 is constitutively present in cells, but is also elevated in 
response to heat shock and other stressors (Arrigo and Landry, 1994; De Thonel et al., 2012; 
Garrido et al., 2012; Arrigo and Gibert, 2013). Hsp27 genes were developmentally regulated 
in mouse, Drosophila and zebrafish and their expression varied depending on the tissue type 
and developmental stage (Davidson et al., 2002; Michaud et al., 2002; Mao and Sheldon, 
2006; Middleton and Sheldon, 2013). Normally, HSP27 exists as large oligomers and under 
stress is phosphorylated by the p38 MAPK pathway resulting in conversion to smaller 
oligomers (Landry et al., 1992; Rogalla et al., 1999; Parcellier et al., 2005; Bryantsev et a. 
2007; Bukach et al., 2009). In mammalian systems, HSP27 is expressed in various tissues 
including lens, heart, kidney, bladder, stomach, skin and muscle and is involved in cellular 
processes such as signal transduction, differentiation and modulation of cytoskeletal proteins 
(Lavoie et al., 1993; Garrido et al., 1997; Mehlen et al., 1997; Garrido et al., 2006; Wettstein 
et al., 2012). Additionally, HSP27 was shown to modulate transcription, translation and 
transduction pathways as well as being involved in tumor cell survival and cytoskeletal 
integrity (Arrigo and Gibert, 2013). HSP27 was found to function as an antioxidant by 
lowering levels of reactive oxygen species by increasing levels of glutathione (Arrigo et al., 
2005). HSP27 is localized primarily in the cytoplasm but has the ability to translocate to the 
nucleus during stressful conditions (Guo et al., 2012; Mymrikov et al., 2012; Schmidt et al., 
2012; Tang et al., 2013). Interestingly, mutated HSP27 was reported to be involved in the 
development of many neurodegenerative diseases (Evgrafov et al., 2004; Arrigo et al., 2007; 
Stetler et al., 2009; Mymrikov et al., 2011; Gurgis et al., 2014).  
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1.2.1.2 Crystallins 
Crystallins are a group of sHSPs that are associated with the lens of the vertebrate 
eye. There are 3 main classes of crystallins, namely, α, β and γ-crystallin (Wistow, 2012). 
The major family of crystallin that is ubiquitously present in different species is the α-
crystallin, which has two isoforms, αA-crystallin and αB-crystallin. Crystallin’s primary 
function is to produce lens transparency and prevent the aggregation of misfolded proteins 
(Clark et al., 2012). αB-crystallin, also known as HSPB5, is a stress-induced sHSP that is 
expressed in many tissues including muscle, heart, kidney, lungs, colon and most importantly 
the lens (Arrigo and Gibert, 2013). It has numerous cellular functions including the 
prevention of protein aggregation by binding client proteins, cytoskeletal protection by 
binding intermediate filaments, regulating cellular growth and adhesion as well as protein 
transport (Arrigo and Gibert, 2013). αB-crystallin forms oligomers similar to HSP27, 
however these structures are less dynamic and range from 400 to 700 kDa (Arrigo and 
Simon, 2010). Similar to HSP27, mutations in α-crystallins were associated with various 
pathologies including cataract, neural and cardiovascular disorders (Vicart et al., 1998; 
Koteiche and Mchaourab, 2006; Arrigo et al., 2007). Recently, α-crystallins were reported to 
play an important role in tumorogensis as constitutive levels of αB-crystallins were detected 
in gliomas, prostate cancer, oral squamous cell carcinomas, renal cell carcinomas and head 
and neck cancer (Arrigo et al., 2007; Chen et al., 2012). 
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1.2.1.3 HSP30 
The HSP30 family of stress-inducible sHSPs have only been detected in frog, fish and 
bird species (Bienz, 1984; Krone et al., 1992; Norris and Hightower, 2002; Franck et al., 
2004; Katoh et al., 2004; Kondo et al., 2004; Wang et al., 2007; An et al., 2014). The number 
of hsp30 genes can vary from species to species. For example, at least 5 members were 
isolated from Xenopus laevis (Bienz, 1984; Krone et al., 1992) and 10 from Rana 
catesbeiana, the American bullfrog (Helbing et al., 1996). In fish, only one hsp30 gene was 
identified in zebrafish whereas up to 18 isoforms were identified in the desert topminnow 
(Poeciliid) (Norris et al., 1995; Elicker and Hutson, 2007). In birds, at least one hsp30-like 
gene, hsp25, was identified in chicken (Katoh et al., 2004). 
Rana catesbeiana HSP30 has not been widely studied but Mulligan-Tuttle and 
Heikkila (2007) demonstrated that Rana hsp30 mRNA and HSP30 protein were not 
constitutively present in the Rana FT fibroblast cell line. However, they were strongly 
induced in response to heat shock and localized primarily in a granular pattern in the nucleus 
and cytoplasm. Kaldis et al. (2004) demonstrated that Rana HSP30 displayed chaperone 
activity as it inhibited heat-induced citrate synthase aggregation in vitro. Additionally, Rana 
HSP30 maintained heat-treated luciferase in a folding competent state as determined using a 
Xenopus oocyte refolding assay. Furthermore, it was suggested that Rana HSP30 may have a 
protective role during development, since it occurred constitutively in the liver of 
metamorphosing tadpoles (Helbing et al., 1996). The pattern of Xenopus laevis hsp30 gene 
expression and function will be discussed in section 1.4.2. 
Studies with the Atlantic salmon, Salmo salar determined that it had a stress-
inducible HSP30 homolog. For example, Lund et al. (2002) reported increased levels of 
 7 
hsp30 mRNA in salmon when their incubation temperature was raised from 16 °C to 22-25 
°C. Similarly, desert topminnow hsp30 was not expressed constitutively but was heat-
inducible and transient in its expression (Norris et al., 1997). Finally, the accumulation of 
hsp30 mRNA was observed in primary cell cultures derived from goldfish caudal fin when 
temperatures were elevated from 20 to 40 °C (Kondo et al., 2004).  
Chicken HSP25, a member of the HSP30 family, was not constitutively expressed but 
was stress-inducible in all tissues examined (Kawazoe et al., 1999). HSP25 accumulation 
was induced by various stressors including heat shock, sodium arsenite and the proteasomal 
inhibitor, lactacystin (Kawazoe et al., 1999; Wang et al., 1981; Katoh et al., 2004). 
Additionally, HSP25 was determined to co-localize with γ-tubulin and accumulate in the 
perinuclear region (Wieske et al., 2001; Katoh et al., 2004). Finally, Katoh et al. (2004) 
demonstrated that overexpression of chicken HSP25 in HeLa cells resulted in inclusion body 
formation. 
 
1.2.2 Heat shock protein 70 (HSP70) 
The HSP70 family of molecular chaperones are found in all organisms and are 
responsible for the regulation of protein folding under normal and stressful conditions 
(Katschinski, 2004). This molecular chaperone family contains constitutively expressed as 
well as stress-inducible members that interact with exposed hydrophobic surfaces of 
unfolded or partially-folded proteins and refold them in an ATP-dependent manner 
(Katschinski, 2004). HSP70 family members include heat shock protein 70 (HSP70), heat 
shock cognate 70 (HSC70), mitochondrial HSP70 and endoplasmic reticulum (ER)-resident 
immunoglobulin binding protein (BiP), also known as glucose regulated protein 78. 
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1.2.2.1 HSP70 
HSP70 contains a highly conserved ATPase domain, a peptide-binding domain and a 
G/C-rich domain required for binding with other co-chaperones (Beere et al., 2000; 
Daugarud et al., 2007). The N-terminal ATPase domain is involved in hydrolyzing ATP 
while the peptide-binding domain is involved in binding and release of non-native proteins. 
Additionally, a Glu-Glu-Val-Asp (EEVD) motif is present in the C-terminal region and 
allows HSP70 to interact with other HSPs and co-chaperones such as HSP40 (Katschinski, 
2004; Daugaard et al., 2007). Binding at this motif maybe also be responsible for HSP70 
chaperone function and target protein specificity. Human cytosolic HSP70 is expressed in a 
tissue-specific and cell-cycle dependent manner during normal steady-state conditions 
(Daugaard et al., 2007). Upregulation of hsp70 gene expression was reported in cells 
encountering stressful conditions including elevated temperature, mycotoxin treatment, 
proteasome inhibition and exposure to arsenite or cadmium (Golli-Bennour and Bacha, 2011; 
Xiong et al., 2013). During these periods of stress, HSP70 protects the cell from aggregation 
of unfolded protein and also directs the refolding of these proteins (Kim et al., 2013). HSP70 
was shown to play an inhibitory role in stress kinase pathways (Sreedhar and Csermely, 
2004) and prevention of apoptosis (Beere and Green, 2001; Stankiewicz et al., 2009). In 
addition to possessing a chaperone function, HSP70 also inhibited apoptosis by recruiting 
and deactivating caspases (Beere et al., 2000; Daugaard et al., 2007; Schlecht et al., 2011). 
Furthermore, high levels of HSP70 were often associated with many types of cancers and 
have been implicated in cancer cell survival (Aghdassi et al., 2007; Ciocca et al., 2013).  
 
 9 
1.2.2.2 Immunoglobulin-binding protein 
Immunoglobulin-binding protein (BiP), is an ER-resident molecular chaperone 
primarily involved in ER protein quality control and in regulating the unfolded protein 
response by binding to unfolded proteins in the ER lumen (Wu et al., 2006). BiP is composed 
of three main domains: the ATPase domain, the peptide-binding domain and the C-terminal 
domain (King et al., 2001). Similar to cytosolic HSP70, BiP is an ATP-dependent chaperone. 
Other functions of BiP include maintaining calcium homeostasis by sequestering calcium 
within the ER, assisting in degradation of proteins through the ERAD pathway (see section 
1.4), signal transduction associated with initiating the unfolded protein response (UPR; see 
section 1.4), cytoprotective and anti-apoptotic effects by binding to caspase-7 and caspase-12 
on the cytosolic side of the ER (Coe and Michalak, 2009; Dudek et al., 2009; Weng et al., 
2011). Bip gene expression is induced by the UPR (see section 1.4), which is triggered by 
increased levels of unfolded protein in the ER (Gal-Yam et al., 2006; Zhang and Zhang, 
2010). BiP levels were reported to increase in response to glucose starvation, treatment with 
glycosylation inhibitor, tunicamycin, and calcium ionophore, A23187 (Kim et al., 2005; Xu 
et al., 2009). Marinesco-Sjogren syndrome, an autosomal dominant polycystic liver disease, 
and Wolcott-Rallison syndrome are just some of the diseases that are associated with 
dysfunction of BiP and its co-chaperones (Senee et al., 2004; Anttonen et al., 2005; 
Waanders et al., 2006). More recently, overexpression of BiP was associated with various 
cancer types. BiP was shown to act as a receptor on the plasma membrane of many tumour 
cells resulting in cancer cell survival, proliferation and metastasis (Su et al., 2010; Zhang and 
Zhang, 2010).  
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1.2.3 Heat shock protein 90 (HSP90) 
The HSP90 family of HSPs contains four members including two cytosolic HSP90 
isoforms, HSP90α and HSP90β, mitochondrial chaperone known as TRAP1 (TNF receptor-
associated protein 1) and ER-associated glucose-regulated protein 94 (GRP94; Felts et al., 
2000). Both HSP90 isoforms contain essential ATP-dependent chaperone activity and are 
constitutively present at a high level in the cell (Sangster et al., 2004). Hereafter in this thesis 
HSP90 will refer to the HSP90α isoform.  
 
1.2.3.1 HSP90  
HSP90 is a ubiquitious molecular chaperone found in all eukaryotes in high 
abundance in the cytoplasm and nucleus and is fundamental to eukaryotic viability (Pearl et 
al., 2008; Erlejman et al., 2014). HSP90 was determined to associate with the transcription 
factor, heat shock factor 1 (HSF1), steroid receptors and signal transduction proteins 
involved in cell growth and proliferation (Zhao and Houry, 2005; Pearl et al., 2008). 
HSP90’s interaction with co-chaperones including HSP70, HSP40 and p23 is essential for its 
proper function (Pratt, 1997; Taipale et al., 2010). HSP90 contains the N-terminal domain 
required for dimerization and ATP binding, a middle domain and a C-terminal domain to 
bind client proteins and co-chaperones. HSP90 also undergoes various post-translational 
modifications including phosphorylation, acetylation and oxidation, which regulate its 
function (Erlejman et al., 2014). HSP90 prevents denaturation and aggregation of proteins 
under normal conditions, assists in assembly/disassembly of multi-protein complexes and 
ensures proper folding and translocation of signalling molecules (Buchner, 1999; Sangster et 
al., 2004). Due to its involvement in many cellular pathways, especially in key processes in 
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oncogenesis such as stabilization of mutant proteins, angiogenesis, self-sufficiency in growth 
signals and metastasis, HSP90 has become a key target for treating various cancers 
(Whitesell and Lindquist, 2005; Trepel et al., 2010). 
 
1.2.3.2 GRP94 
GRP94 is an ER-resident protein that is upregulated as part of the unfolded protein 
response (described in Section 1.4). GRP94 was shown to be induced by a number of ER 
stressors including disturbances in calcium homeostasis, inhibition of glycosylation or 
hypoxia (Lee, 2001; Marzec et al., 2012). GRP94 contains the same domains as HSP90 and 
has similar functions. For example, the N-terminal domain residues in GRP94 that process 
ATP catalysis are the same as those in HSP90. However, unlike HSP90, GRP94 does not 
bind any co-chaperones and functions solely based on conformational changes within its 
domains (Marzec et al., 2012). GRP94 primarily functions as a chaperone and folds protein 
in the ER lumen including substrates of the immunoglobulin family (Marzec et al., 2012). 
Additionally, GRP94 is important for proper translocation and folding of Toll-like receptors 
and integrins (Wu et al., 2012). 
 
1.3 Heat shock response 
The heat shock response (HSR) is a universal cellular homeostatic mechanism that 
has been well characterized in both prokaryotes and eukaryotes. It is activated in response to 
stressful stimuli including elevated temperatures, heavy metals or disease states (Morimoto, 
2008). These stresses can induce an accumulation of unfolded protein, which can interfere 
with regular cellular processes. Accumulation of unfolded protein triggers the upregulation of 
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hsp genes through the transcription factor, heat shock factor (HSF), which binds to the heat 
shock element (HSE), an enhancer found in the regulatory/promoter region of hsp genes 
(Morimoto, 1998; 2008). 
 
1.3.1 Heat shock factors (HSFs) 
C. elegans, Drosophila and S. cervisiae have a single HSF in contrast to plants and 
vertebrates, which have multiple HSFs with specialized functions (Morimoto and Santoro, 
1998; Voellmy, 2004; Fujimoto and Nakai, 2010). To date, 4 HSFs have been identified and 
characterized in vertebrates including HSF1, HSF2, HSF3 and HSF4. In mammals, HSF1 is 
the primary eukaryotic transcription factor responsible for the stress-induced expression of 
hsp genes and is functionally equivalent to the HSF found in Drosophila and yeast 
(Morimoto, 1998; Core and Lis, 2008; Sakurai and Enoki, 2010). Detectable levels of HSF2 
were observed in embryonic tissues and specifically contributed to the developmental 
regulation of hsp gene expression in various organisms including mouse, rat, chicken and 
zebrafish (Rallu et al., 1997; Voellmy, 2004; Abane and Mezger, 2010). HSF3 in 
combination with HSF1 was required for stress-induced expression of hsps in birds (Nakai, 
1999; Fujimoto and Nakai, 2010). Recently, mouse HSF3 was found to have similar 
functionality to that of chicken HSF3 (Fujimoto et al., 2010). Finally, HSF4, which was 
reported to have DNA damage repair capabilities, was expressed in specific mammalian 
tissues including heart, brain, skeletal muscle and pancreas and consisted of two isoforms 
(HSF4a and HSF4b; Nakai et al., 1997; Tanabe et al., 1999; Pirkkala et al., 2001; Cui et al., 
2012). 
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1.3.2 Structure of HSF1 
HSF1 is the stress-inducible member of the HSF family, which is responsible for the 
activation of the heat shock response in eukaryotes (Voellmy, 2004; Fujimoto and Nakai, 
2010). HSF1 consists of a helix-turn-helix DNA binding motif, a carboxy-terminal 
transcriptional transactivation domain and an oligomerization domain consisting of a 
hydrophobic repeat sequence (HR-A/B) essential for trimer formation (Fig. 1; Voellmy, 
2004; Sakurai and Enoki, 2010; Fujimoto and Nakai, 2010). An additional hydrophobic 
repeat sequence (HR-C) is located adjacent to the transcription activation domain. Under 
normal conditions interactions between HR-A/B and HRC contribute to the suppression of 
HSF1 trimerization, while a conserved sequence located between HR-A/B and HR-C is 
thought to negatively regulate DNA-binding and transcriptional activation (Fujimoto and 
Nakai, 2010). 
 
1.3.3 Stress-induced regulation of hsp genes 
In eukaryotes, stress-inducible hsp genes are regulated primarily at the transcriptional 
level via the interaction of HSF1 with the heat shock element (HSE), which is generally 
present in the 5’ promoter of all hsp genes (Morimoto, 1998; Katschinski, 2004; Voellmy, 
2004; Sakurai and Enoki, 2010). Normally HSF1 is bound to HSP90 and histone deacetylase 
6 (HDAC6) and exists as an inactive monomer in the cytoplasm and/or nucleus. In response   
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Figure 1. General structure of HSF1. Schematic representation of HSF1 structural motifs 
that correspond to the helix-turn-helix DNA binding domain, hydrophobic repeat sequences 
(HR-A/B and HR-C), the carboxy terminal transcription activation domain, and regulatory 
domains associated with the suppression of HSF1 activity (adapted from Voellmy, 2004). 
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 to an increase in the intracellular levels of unfolded or misfolded proteins, HSP90 and 
HDAC6 are recruited to aid in protein folding and to prevent their aggregation, thereby 
allowing HSF1 monomers to trimerize (Fig. 2; Bouyalt et al., 2007; Sakurai and Enoki, 
2010). This trimerization results in the activation of HSF1 and subsequent localization to the 
nucleus to initiate transcription of hsp genes. HSF1 also undergoes phosphorylation at serine 
and threonine residues that can lead to potential activation or inactivation of HSF1. 
Constitutively phosphorylated serine residues suppress HSF1 activation, while inducible 
phosphorylated serine residues promote HSF1 activity (Holmberg et al., 2002; Bjork and 
Sistonen, 2010). Sumoylation, the post-translational process by which a small ubiquitin-like 
modifier (SUMO) is added to proteins, can also play a role in regulating DNA binding 
activity and transcriptional activation of HSF1 (Hong et al., 2001; Anckar et al., 2006; Bjork 
and Sistonen, 2010). 
 
1.4 Unfolded protein response 
 The unfolded protein response (UPR) is a complex signalling response in eukaryotes 
that is activated in response to an increase in unfolded or misfolded proteins in the ER. 
Secreted, organelle-targeted or membrane-bound proteins are processed in the ER and 
shipped through vesicular transport to various components in the cell (Ni and Lee, 2007). If 
these proteins are misfolded due to any pathological or physiological condition and cannot be 
repaired, then they are targeted for degradation by the ubiquitin-proteasome system (UPS) 
using the ER-associated degradation (ERAD) pathway (Malhi and Kaufman, 2011).  
  
 17 
 
 
 
 
 
 
 
 
Figure 2. Stress-induced regulation of heat shock response. (1) External stressful stimuli 
cause native proteins in the cell to unfold. (2) HSP90 and HDAC6 are bound to HSF1 under 
normal conditions in the cell. (3) HSP90 and HDAC6 are recruited to prevent aggregation of 
unfolded proteins. (4) This allows HSF1 monomers to trimerize and translocate to the 
nucleus. (5) The HSF1 trimer than binds to the heat shock element at the 5’ promoter of hsp 
genes. (6) HSF1 binding to the HSE results in the transcription of stress-induced HSPs 
including HSP90. 
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ERAD along with the resident molecular chaperones present in ER provide a quality 
control system that ensures unfolded proteins do not accumulate in the ER. If unfolded 
proteins continue to accumulate in the ER, then the cell activates the UPR, which is mediated 
by three transmembrane receptors: activating transcription factor 6 (ATF6), inositol-requiring 
kinase 1 (IRE1) and double-stranded RNA-activated protein kinase (PKR)-like endoplasmic 
reticulum kinase (PERK; Malhi and Kaufman, 2011). These proteins are normally bound to 
and inactivated by BiP, an ER-resident molecular chaperone of the HSP70 family. In the 
presence of an increased amount of misfolded proteins in the ER, BiP dissociates from the 
transmembrane proteins and associates itself with the exposed hydrophobic surfaces of the 
unfolded/misfolded proteins allowing for the activation of PERK, ATF6 and IRE1 (Fig. 3; 
Chakrabarti et al., 2011). The PERK pathway causes translational attenuation through the 
phosphorylation of eIF2α and transduces both pro- and anti-apoptotic signals. Subsequently, 
ATF6 activation, due to dissociation of BiP from ATF6, results in the translocation of ATF6 
to the Golgi, where it is cleaved from the membrane anchor (Chen et al., 2002). The released 
ATF6 translocates to the nucleus and binds promoters containing the ER stress response 
element (ERSE) thus upregulating genes encoding molecular chaperones such as BiP and 
proteins involved in the ERAD pathway (Fig. 3; Adachi et al., 2008).  
 
1.5 Ubiquitin-proteasome system 
The ubiquitin-proteasome system (UPS) is the principle mechanism used by all cells 
to degrade proteins and maintain protein homeostasis in the cell. It is essential for many 
fundamental processes in the cell including cellular differentiation, cell cycle progression, 
proliferation and apoptosis (Mani and Gelmann, 2005; Landis-Piwowar et al., 2006).   
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Figure 3. The Unfolded protein response. 1) Native proteins in the ER unfold under 
stressful conditions. 2) BiP bound to ATF6 in the ER membrane is released and binds 
unfolded proteins. 3) This allows the dimerization of ATF6 and cleavage of its transcription 
factor domain (TFD). 4-5) TFD migrates to the nucleus and causes an up-regulation of ATF6 
target genes including the bip gene. 6) Proteins that cannot be refolded are targeted for 
degradation through the ER-associated degradation (ERAD) pathway.  
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The pathway is broken down into two successive steps: the addition of ubiquitin molecules to 
proteins targeted for degradation followed by their degradation by the 26S proteasome (Fig. 
4A; Yang et al., 2008). 
 
1.5.1 Protein ubiquitination 
Ubiquitin is a 76 amino acid protein that serves as a marker for proteasome 
degradation when it is attached to lysine residues of a targeted protein. The process of 
ubiquitination is controlled by a set of ubiquitin-activating and -conjugating enzymes (E1-
E4; Yang et al., 2008; Lehman, 2009). First, ubiquitin-activating enzyme (E1) activates 
ubiquitin in an ATP-dependent manner through the adenylylation and formation of a thiol-
ester bond at its C-terminus. Subsequently, ubiquitin is transferred to a cysteine residue 
within one of several distinct ubiquitin-conjugating enzymes (E2). With the aid of a third 
enzyme, an E3 ubiquitin ligase, ubiquitin is transferred to a lysine residue of a substrate 
protein. This mechanism continues until the substrate protein is polyubiquitinated (Hershko 
and Ciechanover, 1998). E4 enzymes facilitate the formation of these polyubiquitin chains 
(Koegl et al., 1999). Following, ubiquitination, the substrate protein is then delivered by 
ubiquitin receptor proteins to the proteasome. 
 
1.5.2 The Proteasome 
The 26S proteasome is a complex of multiple protein subunits containing a 19S 
regulator and a 20S proteolytic core (Gallastegui and Groll, 2010; Figure 4B). The 19S  
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Figure 4. Ubiquitin proteasome system. A) Unfolded protein is targeted for degradation by 
ubiquitin-conjugating enzymes that create a polyubiquitin chain and attach it to the lysine 
residues. The ubiquitinated protein is then cleaved into polypeptides by the 26S Proteasome 
and the ubiquitin molecules are recycled. B) The structure of 26S Proteasome containing 19S 
regulatory subunit and the 20S proteolytic core consisting of 2 α and 2 β rings. (Adapted 
from Lee and Goldberg, 1998). 
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regulator serves to control which proteins will be degraded by identifying ubiquitinated 
proteins and then subsequently deubiquitinating them and passing them onto the 20S 
catalytic core for degradation. The 20S proteolytic core contains chymotrypsin-like (CT-
like), trypsin-like (T-like) and peptidyl-glutamyl peptide hydrolyzing-like (PGPH-like) 
peptidases (Murata et al., 2009; Sahara et al., 2014). The 20S core degrades proteins into 
oligopeptides and ubiquitin is released and recycled.  
 
1.5.3 Proteasome inhibitors 
Proteasomal inhibition was shown to have a number of cellular effects including an 
increase in ubiquitinated protein, a decrease in the rate of protein hydrolysis and disruption of 
protein homeostasis (Yang et al., 2008). In mammalian systems, proteasome inhibition 
induced HSP70 in canine kidney cells, HSP27, HSP60, HSP70 and HSP90 in neonatal rat 
cardiomyocytes, HSP72 in caco-2 cells, and HSP27 and αB crystallin in murine lens 
epithelial cells (Bush et al., 1997; Stangl et al., 2002; Pritts et al., 2002; Awasthi and Wagner, 
2005). Inhibition of the ubiquitin-proteasome pathway has been associated with a variety of 
neurological and protein-misfolding diseases including Alzheimer’s, Parkinson’s and 
Huntington’s Disease (Masilah et al., 2000; Ross and Pickart, 2004; Jankowska et al., 2013; 
Lee et al., 2013).  
 
1.5.3.1 MG132 
Carbobenzoxy-leucyl-L-leucyl-L-leucinal (Fig. 5A), more commonly known as 
MG132, is a peptide aldehyde and functions as a reversible inhibitor of the 26S proteasome 
(Rock et al., 1994; Lee and Goldberg, 1998; Guo and Peng, 2013). MG132 inhibits the 20S 
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proteasome activity by covalently binding to the active site of the β-subunits and effectively 
blocking proteolytic activity. MG132 has become a widely employed research tool due to 
study the impact of proteasomal inhibition on various cellular processes including the 
upregulation of the heat shock and unfolded protein response. For example, MG132 was 
shown to increase levels of HSP70 and induce the unfolded protein response in a 
dopaminergic neuronal N27 cell line (Xiong et al., 2013). Additionally, this study also 
demonstrated the formation of aggresome-like inclusion bodies when cells were incubated 
for an extended time with MG132 and that they were cleared through the autophagy-
lysosomal pathway. Moreover, Park et al. (2011) demonstrated that MG132-induced 
apoptosis in human Jurkat T cells via ER-stress mediated apoptotic pathway and also 
upregulated UPR-related chaperones such as BiP. This was also confirmed in human colon 
cancer cells as MG132 treatment resulted in ER stress (Williams et al., 2013). Additionally, 
MG132 treatment of mouse embryonic fibroblasts resulted in the activation of HSF1 and 
resulted in the transcription of hsp genes (Lecomte et al., 2013). Microarray analysis of heat 
shock and MG132 induced-HSP accumulation in a mouse fibrosarcoma cell line suggested 
multiple pathways such as cytokine induction, extracellular matrix remodelling in addition to 
the heat shock response that might be activated (Kim et al., 2011). Recently, Kastle et al. 
(2012) demonstrated that MG132 enhanced the accumulation of HO-1 in human fibroblast 
cells and this phenomenon was mediated by means of the p38MAPK pathway and Nrf-2.  
 
1.5.3.2 Celastrol 
Celastrol (3-Hydroxy-9β,13α-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-
tetraen-29-oic acid) is a quinone triterpene (Fig. 5C). It is extracted from the root of a plant 
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belonging to the Celastraceae family of plants that has been used for hundreds of years in 
traditional Chinese medicine to treat rheumatoid arthritis, bacterial infections and fever 
(Westerheide et al., 2004). Interestingly, it was found that celastrol suppressed protein 
aggregates and toxicity in HeLa cells expressing polygutamine aggregates (Zhang and Sarge, 
2007). Also, celastrol treatment improved brain function and provided neuroprotection in rat 
models for Huntington’s, Parkinson’s and amyotrophic lateral sclerosis (ALS) diseases 
(Kiaei et al., 2005; Cleren et al., 2005). Previous studies examining celastrol demonstrated 
that it inhibits the CT-like activity of the 26S proteasome by associating with the β5 subunit 
of the proteasome (Yang et al., 2006). In mammalian cells, celastrol was determined to 
inhibit proteasome activity and induce hsp accumulation (Westerheide et al., 2004; Yang et 
al., 2006; Trott et al., 2008; Wang et al., 2011). This inhibition of the proteasome was 
suggested as a major contributor to celastrol’s effectiveness in inducing apoptosis in cancer 
cells (Salminen et al., 2010).  
 
1.5.3.3 Withaferin A 
Withaferin A (WA) is a steroidal lactone that is extracted from the roots of 
Ashwaganda (Withania somnifera), a plant that has been used extensively in Aryuvedic 
Indian medicine for centuries (Mandal et al., 2008). Its IUPAC name is (4β,5β,6β,22R)-4,27-
Dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione. Previously, WA was shown to 
inhibit angiogenesis by preventing activation of NF-κB as well as having anti-tumor activity 
(Mohan et al., 2004; Malik et al., 2007; Yang et al., 2007; Mandal et al., 2008). Additionally, 
WA inhibited CT-like activity of the purified rabbit 20S proteasome and 26S proteasome in 
human prostate cancer cells in vitro and in vivo, respectively (Yang et al., 2007).   
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Figure 5. Structures of selected proteasomal inhibitors. A) MG132. B) withaferin A. C) 
celastrol.  
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Molecular docking results indicated that withaferin A (Fig 5B) bound to the active N-
terminal Thr1 residue of the β5 subunit of the 20S proteasome. Recently, it was shown that 
inhibition of HSP90 in WA-treated cells resulted in an increase accumulation of HSP70 (Yu 
et al., 2010). Also, Santagata et al. (2012) showed that the α, β unsaturated carbonyl with 
potential for high thiol reactivity was essential for WA-induced HSP accumulation in glioma 
tumour cells. More recently, WA-associated cytotoxicity in glioblastomas involved the 
induction of the heat shock response through oxidative stress and by altering the MAPK 
signalling pathway (Grogan et al., 2013). Finally, several studies demonstrated that 
withaferin A treatment resulted in activation of the MAP kinases p38 and JNK (Mandal et 
al., 2008; Oh et al., 2008). 
 
1.6 Chemical stressors 
1.6.1 Arsenic 
Arsenic is a chemical stressor that is abundantly present in the environment in a 
variety of forms including arsenite and contributes to renal, cardiovascular and hepatic 
diseases worldwide (Del Razo et al., 2001). Arsenic exposure has been associated with a 
variety of cancers that affect major organs including liver, lungs, kidney, bladder and skin. At 
the cellular level, arsenic in the form of arsenite was shown to induce cytoskeletal collapse, 
apoptosis, metabolic abnormalities and oxidative stress (Li and Chou, 1992; Liu et al., 2001; 
Bode and Dong, 2002). Previously, arsenite also substituted for phosphate in cells and 
affected cellular processes such as DNA replication and ATP synthesis (Del Razo et al., 
2001). Additionally, arsenite induced toxicity at the cellular level through the production of 
reactive oxygen species and generation of free radicals, which induced oxidative damage to 
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proteins. An increase in the relative levels of unfolded or damaged proteins caused by 
arsenite led to the activation of HSF1 and the accumulation of HSPs (Voellmy, 2004; Khalil 
et al., 2006; Guo et al., 2011). Recent mammalian studies demonstrated that arsenite acted as 
a proteasome inhibitor since it inhibited CT-like activity of the proteasome and increased 
relative levels of ubiquitinated proteins (Tsou et al., 2005; Medina-Diaz et al., 2009).  
 
1.6.2 Cadmium  
Cadmium is a toxic heavy metal that has been identified as a human carcinogen. It 
tends to accumulate in the human body, primarily in the kidney, due to anthropogenic 
sources (Mendez-Armenta and Rios, 2007). Waisberg et al. (2003) reported that cadmium 
can cause cancers of the lung, prostate and pancreas due to inhalation of tobacco smoke, 
contaminated food and air pollution. At the cellular level, cadmium induced the production 
of reactive oxygen species, reacted with thiol groups to denature proteins and substituted for 
zinc to form abnormally folded proteins (Waisberg et al., 2003; Galazyn-Sidorczuk et al., 
2009). Additionally, cadmium was shown to inhibit proteasome activity and disrupt E-
cadherin mediated cell adhesion (Joseph et al., 2001; Yu et al., 2008). Cadmium was also 
found to induce hsp and metallothionein expression (Bonham et al., 2003; Liu et al., 2006; 
Mouchet et al., 2006; Blechinger et al., 2007). Prolonged exposure to cadmium also resulted 
in enhanced accumulation of HSPs in renal epithelial cells and rat liver cells (Goering et al., 
1993; Bonham et al., 2003). 
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1.7 RNA stress granules 
Stress or RNA granules are cytoplasmic foci composed of untranslated mRNA, RNA 
binding proteins such as T-cell intracellular antigen (TIA), polyA-binding protein (PABP), 
small ribosomal subunits and a complex assembly of initiation factors (Thomas et al., 2011). 
These complexes, which are usually 0.1 to 2 µm in size, form in cells exposed to adverse 
environmental conditions causing translation initiation inhibition via the phosphorylation of 
eIF2α (Zurla et al., 2011). Stress granules have been hypothesized to stabilize and protect 
mRNA during times of stress (Buchan and Parker, 2009). Stress granule assembly is thought 
to occur by phosphorylation of eIF2α and is activated by distinct eIF2α kinases depending on 
the stress (Kedersha et al., 1999). Stress granules have yet to be purified from stressed cells 
and are only identified by markers such as mRNA-binding proteins TIA1, PABP or G3BP 
(Anderson and Kedersha, 2006). 
Previously it was shown that proteasomal inhibition induced the formation of stress 
granules in HeLa and human embryonic kidney 293 cells by phosphorylating eIF2α via the 
general control nonderepressable 2 (GCN2) stress kinase (Mazroui et al., 2007). Recently, 
Fournier et al. (2010) demonstrated that another proteasomal inhibitor and chemotherapeutic 
agent, bortezomib, also induced the formation of stress granules in HeLa cells. Additionally, 
it was recently discovered that HDAC6 plays a critical role in stress granule assembly and 
inhibition of HDAC6 activity resulted in abolishment of stress granule formation (Kwon et 
al., 2007). Moreover, stress granule formation is thought to occur by movement of 
components via the microtubule network to the perinuclear region in the cytoplasm since 
disruption of the microtubule network inhibited stress granule formation (Ivanov et al., 2003; 
Kwon et al., 2007). 
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1.8 Aggresomes 
Aggresomes are specialized cellular structures containing misfolded, ubiquitinated 
proteins in a cage of intermediate filaments and cytoskeletal proteins such as vimentin 
(Johnson et al., 1998). Aggresome formation results in response to a variety to stressors that 
induce a high number of misfolded proteins. Misfolded proteins tend to aggregate and travel 
to perinuclear regions on microtubule networks since studies have shown that aggresome 
formation was blocked by drugs, such as nocodazole, that depolymerize microtubules 
(Garcia-Mata et al., 1999; Kopito, 2000). While aggresome composition tends to vary based 
on cell type, common components are present and serve as markers including vimentin and 
γ-tubulin. Various studies reported that molecular chaperones such as HSP27, αB crystallin, 
HSP40 and HSP70 may be involved in the formation of aggresome (Ito et al., 2002; Zhang 
and Qian, 2011).  
Aggresomes have a cytoprotective function by becoming cytoplasmic recruitment 
centers for misfolded, damaged or mutated proteins (Taylor et al., 2003) For example, Taylor 
et al. (2003) demonstrated that aggresomes assisted in the rapid turnover of polyglutamine-
aggregates, which was slowed down by inhibiting the formation of aggresomes. Various 
stressors were found to induce aggresome formation in mammalian systems (Ito et al., 2002; 
Song et al., 2008; Bolhuis and Richter-Landsberg, 2010; Jacobson et al., 2012; Taylor et al., 
2012; Xiong et al., 2013). For example, proteasome inhibition induced aggresome formation 
in human embryonic kidney cells, oligodendroglia and glioma cells (Ito et al., 2002; Taylor 
et al., 2012). Also, sodium arsenite and cadmium chloride induced the formation of 
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aggresomes in kidney and yeast cell lines (Heir et al., 2006; Song et al., 2008; Jacobson et 
al., 2012). 
 
1.9 Xenopus laevis as a model organism 
The South African clawed frog, Xenopus laevis, has been used extensively as a model 
system in various research areas including vertebrate development. The large size (1.1 mm in 
diameter) of the Xenopus oocyte/eggs facilitated the in vivo analysis of microinjected DNA, 
mRNA and protein (Etkin, 1982; Ovsenek et al., 1990; Tam and Heikkila, 1995; Sive et al., 
2010; Heikkila, 2010; Moody, 2012). In fact, it was the first in vivo system in which 
heterologous promoter/gene constructs were expressed. Also, pioneering work with Xenopus 
embryos by various researchers including the Nobel Laureate, Dr. John Gurdon, successfully 
cloned Xenopus animals by transferring somatic nuclei into enucleated eggs. In 
developmental studies, X. laevis eggs can be externally fertilized and the embryos develop 
rapidly at room temperature. Furthermore, many X. laevis genes have been isolated and 
characterized. As aquatic animals, Xenopus have a high tolerance for dynamic environmental 
conditions and possess physiological traits that are common to most vertebrates thus ensuring 
that data collected through these systems is applicable to mammals (Burggren and 
Warburton, 2007). 
 
1.9.1 A6 kidney epithelial cell line 
Xenopus continuous cell lines are useful tools for in vitro molecular analyses. A 
number of Xenopus cell lines have been developed over the years including A6, B3.2, KR, 
XF, XL2, XL110, XL-177 and XTC-2 (Smith and Tata, 1991). The most popular cell line 
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used today is the A6 somatic cell line, which was also used in the present study. The X. laevis 
A6 kidney epithelial cell line was isolated from the renal uriniferous tubules of the adult male 
Xenopus by Rafferty (1968). It is easy to maintain and has a quick doubling time, making it 
an ideal tool for cellular and molecular biology research. Unlike other untransformed 
Xenopus cell lines, A6 cells continue to divide after reaching confluency. The A6 kidney 
epithelial cell line has been used widely in diverse areas of research, from genetic profiling 
under zero gravity to the function of Cystic Fibrosis transmembrane conductance regulator 
channels and the role of renal epithelial sodium channels in hypertension (Guerra et al., 2004; 
Ikuzawa et al., 2007; Wang et al., 2009).  
Additionally, the induction of the heat shock response following exposure to 
environmental stressors such as heat shock, sodium arsenite, hydrogen peroxide and 
cadmium chloride has been well characterised in X. laevis A6 kidney epithelial cells (Ohan et 
al., 1998; Phang et al., 1999; Muller et. al, 2004; Gellalchew and Heikkila, 2005; Woolfson 
and Heikkila, 2009; Heikkila, 2010; Brunt et al., 2011; Khamis and Heikkila, 2013). 
Furthermore, proteasomal inhibitors such as lactacystin, MG132, celastrol and curcumin 
were shown to inhibit chymotrypsin (CT)-like activity of the proteasome, enhance the 
relative levels of ubiquitinated protein and induce accumulation of HSPs in A6 cells (Young 
and Heikkila, 2010; Walcott and Heikkila, 2010; Khan and Heikkila, 2011). Finally, sodium 
arsenite and cadmium chloride were found to inhibit proteasome function since these 
stressors inhibited CT-like activity and enhanced accumulation of ubiquitintated proteins in 
A6 cells (Brunt et al., 2012). 
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1.9.2 Xenopus laevis HSP30 family 
HSP30 is a member of the sHSP superfamily of molecular chaperones. All of the 
hsp30 gene family members examined to date, except hsp30E for which there is only a 
partial sequence, are intronless and denoted hsp30A-E. Hsp30A and hsp30B genes were first 
identified by Bienz (1984). However, hsp30A contained an insertional mutation with a stop 
codon in the coding region producing only a 10 kDa protein. The hsp30B gene contained a 
frameshift mutation and was considered a pseudogene. Hsp30C and hsp30D were isolated 
and completely sequenced by Krone et al. (1992) and encoded 24 kDa proteins (Krone et al., 
1992). Only the promoter and the N-terminal coding region of hsp30E were isolated. 
Analysis of the HSP30 amino acid sequence revealed the presence of a C-terminal α-
crystallin domain (ACD) flanked by poorly conserved N-terminal region and C-terminal 
extension. HSP30 is the dominant stress-inducible sHSP in Xenopus and has counterparts in 
birds, fish and other frogs but not in mammals as mentioned previously. Xenopus HSP27 is a 
homolog of the human HSP27 and has only 19 % sequence identity with Xenopus HSP30C 
as mentioned previously (Tuttle et al., 2007). Similarly, in the minnow, HSP27 shared greater 
identity with human and avian HSP27 than with HSP30 (Norris et al., 1997). This suggested 
that the HSP30 and HSP27 families of proteins are unique. Extensive immunoblot and 
immunocytochemical analyses did not detect the presence of hsp27 mRNA or HSP27 protein 
in Xenopus laevis A6 cells (Gauley and Heikkila, unpublished data). 
Initial studies determined that heat shock-induced hsp30 genes were developmentally 
regulated. During embryogenesis, hsp30C was first heat-inducible at the late neurula/early 
taildbud stage of Xenopus development, while hsp30D was not heat-inducible until 
midtailbud (Heikkila, 2003). In contrast, Hsp90, Hsp70 and Hsp47 genes were heat shock-
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inducible after the midblastula stage (Ali et al., 1996a; Ali et al., 1996b; Lang et al., 2000; 
Hamilton and Heikkila, 2006; Heikkila, 2010). In X. laevis A6 kidney epithelial cells, various 
stresses including heat shock, sodium arsenite, herbimycin A, cadmium and hydrogen 
peroxide were found to induce hsp30 gene expression (Briant et al., 1997; Ohan et al., 1998; 
Phang et al., 1999; Muller et al., 2004; Woolfson and Heikkila, 2009; Young et al., 2009; 
Khamis and Heikkila, 2013). Immunocytochemical analysis of A6 cells revealed that heat 
shock or sodium arsenite-induced HSP30 accumulation occurred primarily in the perinuclear 
region in a granular or punctate pattern (Gellalchew and Heikkila, 2005). Interestingly, 
exposure of A6 cells to concurrent mild sodium arsenite and heat stress greatly enhanced 
hsp30 gene expression compared to each stressor individually (Young et al., 2009). Recent 
studies determined that proteasomal inhibitors, such as lactacystin, MG132, celastrol and 
curcumin, induced HSP30 accumulation in A6 cells (Young and Heikkila, 2010; Walcott and 
Heikkila, 2010; Khan and Heikkila, 2011). Immunocytochemical analysis revealed that these 
proteasomal inhibitors induced the formation of large HSP30 cytoplasmic structures (Young 
and Heikkila, 2010; Khan and Heikkila, 2011). It was hypothesized that these large HSP30 
structures might be stress granules or aggresomes.  
HSP30C and HSP30D were determined to function as molecular chaperones since 
they inhibited heat-induced target protein aggregation and maintained heat- or chemically-
denatured luciferase in a folding competent state (Fernando and Heikkila, 2000; Fernando et 
al., 2002; Abdulle et al., 2002). For example, Xenopus HSP30C and HSP30D prevented heat- 
and chemically-induced aggregation of citrate synthase in an ATP-independent fashion 
(Fernando and Heikkila, 2000; Abdulle et al., 2002). Additionally, site-specific mutagenesis 
also revealed that the C-terminal region was essential for proper HSP30 folding and optimal 
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chaperone activity (Fernando and Heikkila, 2000; Abdulle et al., 2002; Fernando et al., 
2002). Finally, Fernando et al. (2003) demonstrated that HSP30 was phosphorylated in vivo 
by the p38 MAPK pathway during recovery from stress and resulted in production of smaller 
oligomeric structures and inhibition of molecular chaperone activity. 
 
1.9.3 Xenopus laevis HSP70 family 
The Xenopus HSP70 family consists of constitutively expressed HSC70, stress-
inducible HSP70, mitochondrial HSP70 (mtHSP70) and BiP. Members of the stress-
inducible HSP70 family were first isolated from Xenopus by Bienz (1984). Coding regions of 
hsc70.I, hsc70.II and bip genes were isolated and characterized in our laboratory (Ali et al., 
1996a; Ali et al., 1996b; Miskovic et al., 1997). 
 
1.9.3.1 Xenopus laevis HSP70 
Several studies demonstrated that hsp70 mRNA and protein were present 
constitutively during Xenopus oogenesis (Bienz, 1984; Davis and King, 1989, Horrell et al., 
1987). Hsp70A and Hsp70B transcripts were maintained throughout oocyte maturation, 
fertilization and cleavage. During development hsp70 mRNA was first heat inducible after 
the midblastula transition (MBT), which marks the activation of the zygotic genome (Krone 
and Heikkila, 1988; Ovsenek and Heikkila, 1990). Additionally, whole mount in situ 
hybridization, which was employed to detect the spatial pattern of heat-inducible hsp70 
mRNA in embryos, determined that it accumulated in a tissue-specific manner in embryos 
after the midblastula stage (Lang et al., 2000). As found with HSP30, HSP70 accumulation in 
A6 cells was induced in response to a variety of stressors including heat shock, sodium 
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arsenite, cadmium and proteasomal inhibitors including MG132, lactacystin, celastrol and 
curcumin (Heikkila, 2004, Woolfson and Heikkila, 2009; Young et al., 2009; Young and 
Heikkila, 2010; Walcott and Heikkila, 2010; Khan and Heikkila, 2011; Khamis and Heikkila, 
2013).  
 
1.9.3.2 Xenopus laevis BiP 
Xenopus BiP shared greater amino acid sequence identity with BiP from other 
vertebrates than with Xenopus HSP70 (Miskovic et al., 1997). Analysis of the protein 
domains of Xenopus BiP determined that it contained an N-terminal ATPase domain, similar 
to HSP70, as well as a C-terminal KDEL (ER-retention signal sequence). In developmental 
studies, northern blot and immunoblot analyses determined that constitutive levels of bip 
mRNA and BiP protein were present in unfertilized eggs and at all developmental stages 
examined (Winning et al., 1989; 1991; Miskovic and Heikkila, 1999). This was confirmed by 
whole mount in situ hybridization experiments, which detected bip mRNA across the surface 
of the gastrula embryo while in neurulae it was present in the neural folds, neural plate and 
around the blastopore (Miskovic and Heikkila, 1999). In neurula and later stages, bip mRNA 
accumulation was enhanced after treatment with the calcium ionophore, A23187 and 
tunicamycin. Also, constitutive levels of bip mRNA were detected in all adult tissues 
examined (Miskovic et al., 1997). Finally, in Xenopus A6 cells, bip mRNA was detected 
constitutively and enhanced by tunicamycin, dithiothreitol and A23187 (Miskovic et al., 
1997).  
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1.10 Research objectives 
While much is known about stress-induced sHSP regulation and function in 
mammals, less is known about these molecular chaperones, such as HSP30, in Xenopus 
laevis. The primary question that I wanted to address in this thesis was whether Xenopus 
HSP30 multimeric complexes associated with aggresomes and/or stress granules in A6 
kidney epithelial cells. The present study has focused on an examination of the relative levels 
of HSP30 and HSP70 during recovery from heat stress as well as the intracellular localization 
and possible function of proteasomal inhibitor-induced HSP30 in Xenopus laevis A6 kidney 
epithelial cells. Furthermore, this thesis has investigated, for the first time inA6 cells, the 
formation of stress granules and aggresomes and their possible association with HSP30 
multimeric complexes. The specific questions that were examined in the thesis are as 
follows: 
1) What are the relative levels of HSP30 and HSP70 accumulation in A6 cells during recovery 
from heat shock? 
2) Is the p38 MAPK pathway involved in the formation of HSP30 multimeric complexes during 
recovery from thermal stress? 
3) What effect do proteasome inhibitors (MG132, withaferin A, celastrol, cadmium and arsenite) 
have on HSP30, HSP70, BiP, GRP94 and heme oxygenase-1 accumulation? 
4) Do stress-induced stress (RNA) granules and/or aggresomes form in A6 cells in response to 
proteasomal inhibitors? 
5) Is there an association of large HSP30 multimeric complexes with stress granules and/or 
aggresomes in A6 cells treated with proteasomal inhibitors? 
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Chapter 2: Experimental Procedures 
2.1 Maintenance and treatment of Xenopus laevis A6 kidney epithelial cells 
X. laevis A6 cells were obtained from the American Type Culture Collection (ATCC, 
Rockville, MD) and were grown in 70 % Leibovitz L-15 Media containing 10 % (v/v) fetal 
bovine serum (100 U/ml) and 1 % penicillin/streptomycin (100 units penicillin, 100 µg/ml 
streptomycin; all purchased through Sigma-Aldrich, Oakville, ON) at 22 °C in T75 cm
2
 BD 
falcon culture flasks (BD Biosciences, Mississauga, ON). Upon confluency, cells were 
washed with 1 ml of versene [0.02 % (w/v) KCl, 0.8 % (w/v) NaCl, 0.02 % (w/v) KH2PO4, 
0.115 % (w/v) Na2HPO4, 0.02 % (w/v) sodium ethylenediaminetetra-acetic acid (Na2 
EDTA)], followed by a 1 min incubation with 2 ml of fresh versene. Then 1 ml of 1X trypsin 
(Sigma-Aldrich) diluted in 100 % Hank’s Balanced Salt Solution (HBSS; Sigma-Aldrich) 
was added until cells began to detach from the flask. Ten ml of fresh L-15 media was then 
added to the detached cells. The cell suspension was then divided evenly into additional 
flasks. Cell treatments were performed 2 days after cell passaging to allow the cells to reach 
90-100 % confluence.  
For initial set of experiments, cells were heat shocked in a water bath set at 33 °C for 
2 h and allowed to recover at 22 °C. Flasks of cells were treated either before for 2 h or after 
heat shock for the duration of the treatment with 100 µM cycloheximide (dissolved in water; 
Sigma-Aldrich), 10 µM SB203580 (dissolved in dimethyl sulfoxide (DMSO); Sigma-
Aldrich) or 30 µM MG132 (carbobenzoxy-L-leucyl-L-leucyl-L-leucinal dissolved in DMSO; 
Sigma-Aldrich; Young and Heikkila, 2010). For the study of ER and cytosolic molecular 
chaperones as well as presence of aggresomes or stress granules, cells were either maintained 
at 22 °C containing the vehicle, DMSO (Control cells) or treated with 7 µM A23187 
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(dissolved in DMSO; Sigma-Aldrich), 30 μM MG132, 2.5 μM celastrol (dissolved in DMSO; 
Cayman Chemical, Ann Arbor, MI, USA; Walcott and Heikkila, 2010) or 5 μM withaferin A 
(dissolved in DMSO; Enzo Life Sciences, Plymouth Meeting, PA) at 22 C for periods of 
time ranging from 2 to 24 h. Cells were rinsed using 65 % HBSS and removed via scraping 
in 1 ml of 100 % HBSS. Cells were centrifuged at 21,920 x g for 1 min and the resulting 
pellets were stored at -80 °C until protein or RNA isolation. 
 
2.2 Cell-based proteasome assay 
To evaluate the effect of A23187, celastrol, withaferin A or MG132 on proteasomal 
activity in A6 cells, The Proteasome-Glo Chymotrypsin-Like cell based luminescent assay 
kit was obtained from Promega (Promega, Madison, WI). Proteasome-Glo Cell-Based 
Reagents each contain a specific luminogenic proteasome substrate (Suc- Leu-Leu-Val-Tyr-
Glo substrate for chymotrypsin-like activity) in a buffer optimized for cell permeabilization, 
proteasome activity and luciferase activity. The proteasome cleavage generates an 
aminoluciferin substrate that is consumed by luciferase to produce a luminescent signal at a 
rate proportional to proteasome activity. Proteasome-Glo™ Cell-Based Buffer and Luciferin 
Detection Reagent were equilibrated to room temperature in the dark and mixed with the 
Suc-Leu-Leu-Val-Tyr-aminoluciferin (Suc-LLVY-aminoluciferin) substrate to produce the 
Proteasome-Glo™ Reagent, which was used to detect the chymotrypsin-like activity. Flasks 
of A6 cells were treated with 7 µM A23187 or 30 μM MG132 for 24 h, or 2.5 μM celastrol 
or 5 μM withaferin A for 18 h. After treatments, cells were washed with 2 mL of versene and 
then with 1 mL of 1X trypsin until the cells began to detach from the T75 cm
2
 BD falcon 
culture flask. Nine ml of fresh L-15 media was then added to the flask and the media was 
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pipetted up and down to rinse the flask surface and allow for even distribution. The cell 
suspension was then removed from the flask and placed into a 15 mL falcon tube. Cells were 
pelleted at 4 °C by gentle centrifugation at 2,400 x g for 5 min. Following centrifugation 
excess media was removed and pellets were washed in 5 mL of fresh L-15 media and then 
centrifuged again at 2,400 x g for 5 min at 4 °C. A6 cells were then resuspended in 5 mL of 
fresh L-15 media. For each sample, the total number of cells per mL was determined using a 
Bright-Line haemocytometer (Hausser Scientific, Horsham, PA). 
Approximately 15,000 cells per well were added to white-walled 96 well plates along 
with an L-15 blank. Proteasome-Glo™ Reagent was allowed to reach room temperature 
before being added to the 96-well plate in a 1:1 ratio (100 µL sample: 100 µL reagent). The 
contents of the plate were then mixed for 2 min on the shaker and allowed to incubate at 
room temperature for 45 min before detection of luminescence. The luminescence of each 
sample was measured using the Victor
3
 luminometer (Perkin Elmer Inc., Waltham, MA) 
containing a filter set at 340/480 nm. Values were then compared to a blank control 
(Proteasome-Glo cell-based reagent + L-15 media) and a no-treatment control (Proteasome-
Glo cell-based reagent + L-15 containing DMSO). Measurements were repeated 3 times and 
statistical analysis was performed through analysis of variance (ANOVA) followed by 
Tukey’s Multiple comparison post-test. 
 
2.3 Antisense riboprobe production 
2.3.1 Hsp30C, hsp70, bip and eIF1α template construction 
The open reading frame of the hsp30C gene was previously inserted into the pRSET 
expression vector (Invitrogen, Carlsbad, California) by Pasan Fernando (Fernando and 
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Heikkila, 2000). The coding region of hsp70 genomic DNA was previously isolated (Lang et 
al., 2000) and inserted into the plasmid pSP72 (Promega, Nepean, Ontario). The BiP cDNA 
was cloned into the XhoI and EcoRI sites of pBluescript KS+ (Gibco/BRL Laboratories, 
Burlington, ON) (Miskovic et al, 1997). The eIF1α cDNA clones (Genbank accession No. 
BG160504) in pCMV-Sport6 vectors (Invitrogen Life Technologies, Frederick, MD) were 
obtained from the ATCC. Plasmids containing the hsp30C, hsp70, bip and eIF1α insert were 
transformed into Escherichia coli DH5α cells (Fig. 6). Individual colonies were inoculated 
into 15 mL centrifuge tubes and grown overnight in 5 mL of LB broth [1% (w/v) tryptone-
peptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, pH 7.5] containing 100 μg/mL ampicillin 
(Bioshop, Burlington, Ontario) at 37 ºC.  
 
2.3.2 Plasmid isolation and in vitro transcription 
Bacterial cells were pelleted in a centrifuge at 2,400 x g for 10 min at 4 ºC. Plasmid 
DNA was isolated using phenol: chloroform extraction and re-suspended in 50 μL distilled 
water and stored at -20 °C. The plasmid containing the hsp30C, hsp70, bip or eIF1α insert as 
mentioned above was linearized using the PvuII, MluNI, BamHI or SmaI restriction enzyme, 
respectively (Figure 6, Roche, Indianapolis, IN). In vitro transcription was used to generate 
digoxygenin (DIG)-labelled riboprobes. Each in vitro transcription reaction contained 4 μL 
of linearized DNA template, 4 μL of rNTP mix [2.5 mM rGTP, 2.5 mM rATP, 2.5mM rCTP, 
1.625 mM rUTP (Promega), 0.875 mM DIG-11-UTP (Roche), 1.5 μL diethylpyrocarbonate 
(DEPC)-treated water, 4 μL of 100 mM dithiothreitol to a final concentration of 20 mM 
(Promega), 4 μL of 5X transcription buffer to a final concentration of 1X (Fermentas, 
Burlington, Ontario), 0.5 μl Rnase inhibitor (Fermentas) and 40 U of SP6 RNA polymerase   
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Figure 6. Templates for hsp30C, hsp70, bip and eIf1α in vitro transcription. A) The 
coding region of the hsp30 gene was previously cloned in the pRSETB plasmid into the 
BamHI and EcoRI sites (Fernando and Heikkila, 2003). To generate antisense riboprobe 
template, the plasmid was linearized with PvuII and transcribed with SP6 polymerase. B) 
The coding region of the hsp70 gene contained in pXL16P (Bienz, 1984) was cloned into the 
SmaI and Pst1 sites of pSP72 (Promega), generating pSP72-hsp70. To generate antisense 
riboprobe template, the plasmid was linearized with MluNI and transcribed with SP6 
polymerase. C) The BiP cDNA was cloned into the XhoI and EcoRI sites of pBluescript KS+ 
(Miskovic et al, 1997). BiP antisense riboprobe was generated by linearization of the plasmid 
with BamHI and transcribed with T7 polymerase. D) The coding region of eIF1α was cloned 
into pCMV-SPORT6, generating pCMV-SPORT6-eIf1α (ATCC). To synthesize antisense 
riboprobe, pCMV-SPORT6-ef-1was linearized with SmaI and transcribed in vitro with T7 
polymerase. 
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for hsp30C and hsp70 or T7 RNA polymerase for bip and eIF1α (Roche)]. The in vitro 
transcription reaction was performed for 1 h at 37°C. To remove any remaining DNA 
template, 2 μL of RNase-free DNase 1 (Roche) was added for 10 min at 37 ºC. In vitro 
transcripts were then precipitated with the addition of 10 μL of 3 M sodium acetate (pH 5.2), 
80 μL of TES [10 mM Tris (pH 7.4), 5 mM EDTA (pH 8.0), 1% (w/v) SDS] and 220 μL of 
ice-cold 100% filtered ethanol and re-suspended in 21 μL of DEPC-treated water. One μL 
was electrophoresed to verify the presence of the in vitro transcript. The remaining 20 μL 
was stored at -80 ºC until Northern hybridization analysis. 
 
2.4 RNA isolation 
RNA was isolated from A6 cells using the QIAgen RNeasy Mini Kit (QIAgen, 
Mississauga, Ontario) as described in the RNeasy Mini Handbook (2009) animal cell 
protocol. Isolated RNA was suspended in DEPC-treated water and quantified using the 
NanoDrop ND-1000 (NanaDrop, Waltham, Massachusetts) spectrophotometer at a 
wavelength of 260 nm. RNA integrity was analyzed by electrophoresing 2 μg of each RNA 
sample on a 1.2% (w/v) formaldehyde agarose gel [1.2% (w/v) agarose, 10% (v/v) 10X 
MOPS, 16% (v/v) formaldehyde]. Prior to loading, 10 μL of loading buffer [1 μL 10X 
MOPS, 1.6 μL formaldehyde, 2 μL RNA loading dye (0.2% bromophenol blue, 1 mM EDTA 
(pH 8.0), 50% (v/v) glycerol), 5 μL formamide, 0.5 μg/mL ethidium bromide] was added to 
each sample. Samples were then heat denatured for 10 min at 68 ºC, cooled on ice for 5 min, 
and then loaded onto the gel and electrophoresed for 1 h at 90 V. Distinct 18S and 28S rRNA 
banding indicated intact RNA. 
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2.5 Northern hybridization analysis 
For Northern hybridization analysis, an antisense riboprobe for Xenopus hsp30C, 
Xenopus hsp70, Xenopus bip and eIf1α (see Section 2.3) was used. Ten μg of total isolated 
RNA was electrophoresed in a 1.2 % formaldehyde agarose gel as described previously. The 
loading buffer contained all components except ethidium bromide and the gel was 
electrophoresed for 3 h at 70V. Following electrophoresis, the RNA in the gel was denatured 
by soaking the gel in 0.05 N NaOH for 20 min. Then the gel was rinsed in DEPC-treated 
water and soaked twice for 20 min each in fresh 20X SSC buffer [3 M sodium chloride, 300 
mM sodium citrate]. The RNA was then transferred overnight to a positively charged nylon 
membrane (Roche) by capillary action.  
The following morning, RNA on the membrane was UV-crosslinked twice using a 
UVC-515 Ultraviolet Multilinker. The quality of the transfer was checked using 1X 
reversible blot stain (Sigma Aldrich). The stained blot was scanned and then incubated in 50 
mL of pre-heated prehybridization buffer [50% (v/v) formamide, 5X SSC, 0.02% (w/v) SDS, 
0.01% (w/v) N-lauryl sarcosine, 2% (w/v) blocking reagent] in a hybridization bag at 68 ºC 
for 4 h in a Shake N’ Bake Hybridization Oven. After prehybridization, the buffer was 
replaced with hybridization buffer (same components as prehybridization buffer) containing 
20 μL of either hsp30C, hsp70, bip or eIf1α DIG-labelled antisense riboprobe and the 
membrane was returned to the hybridization oven overnight.  
The following morning, the membrane was then washed to remove any unbound 
probe. It was first washed twice in 2X SSC at room temperature, then once each in 0.5X SSC 
and 0.1X SSC, both at 68ºC for 15 min. Each of these three SSC washing solutions contained 
0.1% (w/v) SDS. The blot was then equilibrated for 1 min at room temperature in washing 
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buffer [100 mM maleic acid buffer, 0.3% (v/v) Tween-20 (Sigma Aldrich)] and blocked 
using blocking solution [2% (w/v) blocking reagent, 10% (v/v) maleic acid buffer] for 1 h at 
room temperature. The blot was then incubated in blocking solution containing 1:8000 
alkaline phosphatase conjugated anti- DIG-Fab fragments for 30 min. The membrane was 
then washed twice in washing buffer for 10 min each and then equilibrated in detection 
buffer [0.1 M Tris-HCl (pH 9.5), 0.1 M NaCl] for 2 min prior to detection using CDP-star, a 
chemiluminescent reagent, which was applied to the membrane and allowed to develop in a 
hybridization bag for 10 min. The membrane was then visualized on a DNR 
Chemiluminescent Imager (DNR Bioimaging Systems, Kirkland, Quebec) for up to 15 min 
depending on the strength of the signal. 
 
2.6 Protein isolation, quantification and immunoblot analysis 
2.6.1 Protein isolation and quantification 
Protein was isolated from A6 cells using a lysis buffer solution at pH 7.4 containing 
200 mM sucrose, 2 mM EDTA, 40 mM NaCl, 30 mM HEPES, 1% (w/v) SDS and 1 % 
protease inhibitor cocktail (Promega). It should be noted here that the lysis buffer used for 
samples in preparation for western blotting with mouse anti-ubiquitin antibody contained 10 
mM N-ethylmaleimide (Sigma-Aldrich) to inhibit deubiquitination of proteins. The cells 
were homogenized in the lysis buffer by sonication (output 4.5, 60% duty cycle) on ice for 15 
bursts using a Fisher Scientific Sonic Dismembrator 100 (Fisher Scientific) and subsequently 
centrifuged at 21,920 x g for 30 min at 4 °C. The supernatant containing the protein sample 
was removed.  
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Protein was quantified using a bicinchoninic acid (BCA) protein assay kit (Pierce, 
Rockford, IL). A bovine serum albumin (BSA; BioShop) protein standard was created by 
diluting BSA in distilled water at concentrations ranging from 0 to 2 mg/ml. Protein samples 
were diluted to a concentration of 1:2 in distilled water. Ten μL of BSA standards and protein 
samples were transferred in triplicate into a 96 well clear polystyrene plate. Then 80 μL of 
BCA reagent A and B (Pierce) at a ratio 50:1 were added to the BSA and protein samples. 
The plate was incubated at 37 °C for 30 min and then read at 562 nm using a Versamax 
Tunable microplate reader (Molecular Devices, Sunnyvale, CA). A standard curve was 
created using the concentrations of the BSA protein standards, which was used to determine 
the concentration of the protein samples. Protein samples were stored at -20 °C until further 
use. 
 
2.6.2 Immunoblot analysis 
Immunoblot analysis was performed using 20, 40 or 60 µg of protein (the highest 
amount was used for the analysis of ubiquitinated protein) and sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) as described previously (Khan and 
Heikkila, 2011). Specifically, separating gels [10-12% (v/v) acrylamide, 0.32% (v/v) n’n’-bis 
methylene acrylamide, 0.375 M Tris (pH 8.8), 1% (w/v) SDS, 0.2% (w/v) ammonium 
persulfate (APS), 0.14% (v/v) tetramethylethylenediamine (TEMED)] were prepared, poured 
and allowed to polymerize for 25 min with 100% ethanol layered on top. Ethanol was poured 
off and the stacking gel [4% (v/v) acrylamide, 0.11% (v/v) n’n’-bis methylene acrylamide, 
0.125 M Tris (pH 6.8), 1% (w/v) SDS, 0.4% (w/v) APS, 0.21 % (v/v) TEMED] was 
prepared, poured and allowed to polymerize for 25 min. A6 cell protein samples were 
 52 
aliquoted and loading buffer [0.0625M Tris (pH 6.8), 10% (v/v) glycerol, 2% (w/v) SDS, 5% 
(v/v) β-mercaptoethanol, 0.00125% (w/v) bromophenol blue] was added, to a final 
concentration of 1X. Samples and molecular weight markers (BioRad, Mississauga, ON) 
were denatured via boiling for 10 min, cooled on ice for 5 min and pulse-centrifuged prior to 
loading. Polyacrylamide gels were electrophoresed on a BioRad Mini Protean III gel system 
(BioRad) with 1X running buffer [25mM Tris, 0.2M glycine, 1 mM SDS] at 90 V until 
samples reached the separating gel, at which time the voltage was turned up to 160 V until 
the dye front reached the bottom of the gel.  
Pure nitrocellulose transfer blot membranes (BioRad) were incubated for 30 min in 
transfer buffer [25 mM Tris, 192 mM glycine, 20% (v/v) methanol]. After electrophoresis, 
the stacking gel was cut away and the remainder of the gel was soaked in transfer buffer for 
15 min. Protein was transferred to the nitrocellulose membrane with a Trans-Blot Semi-Dry 
Transfer Cell (BioRad) at 25 volts for 20 min. Blots were then stained with Ponceau S stain 
[0.19% (w/v) Ponceau S (Sigma-Aldrich), 5% (v/v) acetic acid] for 10 min to determine 
transfer efficiency. The membrane was destained with MilliQ water and then scanned 
photographed. The membrane was subsequently blocked in 5 % blocking solution [20 mM 
Tris (pH 7.5), 0.1% Tween 20 (Sigma-Aldrich), 300 mM NaCl, 5% (w/v) Nestle
®
 Carnation 
skim milk powder] for 1 h to prevent non-specific binding. Immunodetection was carried out 
via either the use of polyclonal rabbit anti-Xenopus HSP30 antibody (Fernando and Heikkila, 
2003); 1:500 dilution, the polyclonal rabbit anti-Xenopus HSP70 antibody (Gauley et al., 
2008); 1:250 dilution, the polyclonal rabbit anti-BiP antibody (Sigma-Aldrich); 1:1000 
dilution, the monoclonal rat anti-GRP94 antibody (Cedarlane); 1:1000 dilution, the 
polyclonal rabbit anti-actin antibody (Sigma-Aldrich); 1:200 dilution, the monoclonal mouse  
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Table 1. Dilution specifications for antibodies used in western blot analysis 
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Primary Antibody Secondary Antibody 
Comments 
Name Dilution Name Dilution 
Rabbit anti-
Xenopus HSP30 
1:500 
Goat anti-rabbit IgG 
AP-conjugate 
1:2000 
Prepared by Heikkila 
lab 
Rabbit anti-
Xenopus HSP70 
1:250 
Goat anti-rabbit IgG 
AP-conjugate 
1:3000 
Prepared by Abgent 
(San Diego, CA) 
Rabbit anti-BiP 1:1000 
Goat anti-rabbit IgG 
AP-conjugate 
1:3000 
Purchased from 
Sigma Aldrich 
Rat anti-GRP94 1:1000 
Goat anti-rat IgG 
AP-conjugate 
1:3000 
Purchased from 
Cedarlane 
Rabbit anti-actin 1:200 
Goat anti-rabbit IgG 
AP-conjugate 
1:3000 
Purchased from 
Sigma Aldrich 
Mouse anti-
ubiquitin 
1:150 
Goat anti-mouse IgG 
AP-conjugate 
1:1000 
Purchased from 
Zymed 
Rabbit anti-p38 
MAPK 
1:200 
Goat anti-rabbit IgG 
AP-conjugate 
1:2000 
Purchased from Cell 
Signal Technology 
Rabbit anti-
phospho p38 
MAPK 
1:200 Goat anti-rabbit IgG 1:2000 
Purchased from Cell 
Signal Technology 
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anti-ubiquitin antibody (Zymed, San Francisco, CA); 1:150 dilution or the polyclonal rabbit 
anti-p38 MAPK (Cell Signal Technology; 1:200 dilution) or the polyclonal rabbit anti-
phosphorylated p38 MAPK (Cell Signal Technology; 1:200 dilution) (Table 1). Excess 
unbound antibody was removed by rinsing the membrane with 1X TBS-T [20 mM Tris, 300 
mM NaCl, (pH 7.5), 0.1% (v/v) Tween 20]. The membrane was then incubated for 1 h with 
blocking solution containing the secondary antibody (alkaline phosphatase-conjugated goat-
anti-rabbit, rat or mouse (BioRad)). The secondary antibody dilution was dependent on the 
primary antibody employed, which is outlined in table 1. For detection, the membrane was 
incubated in alkaline phosphatase detection buffer [alkaline phosphatase buffer (100 mM 
Tris base, 100 mM NaCl, 50 mM MgCl2 (pH 9.5)), 0.3% 4-nitro blue tetrazolium (NBT; 
Roche), 0.17% 5-bromo-4-chloro-3-indolyl phosphate, toluidine salt (BCIP; Roche)] until the 
bands were visible. 
 
2.7 Pore exclusion limit gel electrophoresis 
Immediately following treatment, A6 cells were collected as described previously 
(see section 2.1) and 300 uL of prepared lysis buffer [50 mM Tris (pH 7.5), 1% Nonidet P-
40, 2 mM EDTA, 100 mM NaCl, 50 mM MgCl2, 10 mM N-Ethylmaleimide and 1X Protease 
inhibitor cocktail (Promega)] was added to each sample. The cell pellet was resuspended 
using a pipet and the cell lysate was incubated on a rotator for 2 h at 4 °C. Cellular debris, 
nuclei and insolubilized material was pelleted using a refrigerated Eppendorf microcentrifuge 
at 21,920 x g at 4 °C for 10 min. The supernatant was transferred to a fresh tube and loading 
buffer without SDS and β-mercaptoethanol [0.0625M Tris (pH 6.8), 10% (v/v) glycerol and 
0.00125 % (w/v) bromophenol blue] was added to a final concentration of 1X. 
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The protein samples were resolved on a previously prepared 2 to 22.5 % (0 to 12.5 % 
glycerol) gradient gel. The gradient gel was prepared using 2 solutions, namely, degassed, 
chilled, 2 % acrylamide, 0.375 M Tris (pH 8.8) and 22.5 % acrylamide, 0.375 M Tris (pH 
8.8), 12.5% glycerol, which were loaded into the reservoir and mixing chamber, respectively, 
of a BioRad gradient maker. APS and TEMED were added to initiate polymerization, and the 
acrylamide solutions were mixed in the mixing chamber of the gradient maker by a stir bar as 
the solution was pumped into the BioRad multicasting chamber via a peristaltic pump. The 
liquid filled the gel sandwiches (1.0 mm spacer) in the chamber from the top, generating 2 to 
22.5 % (0 to 12.5 % glycerol; top to bottom) continuous acrylamide gradient gels. The combs 
(1.0 mm 1-D comb position at the top) were added and gels were left to polymerize for 1 h, 
after which the combs were removed and wells were washed with MilliQ water. The gels 
were then chilled at 4 °C until ready to use. The gels were electrophoresed in 1X running 
buffer without SDS [25mM Tris, 0.2M glycine] at 90 V for 3 h at 4 °C to separate the 
proteins to their pore exclusion limits (Fernando and Heikkila, 2003). Following 
electrophoresis the gels were transferred to nitrocellulose membranes and immunoblotted 
with anti-Xenopus HSP30 antibody as described previously (see section 2.6.2). 
 
2.8 Co-immunoprecipitation analysis 
Immediately following treatment, A6 cells were rinsed using 65 % HBSS and 10 mM 
N-ethylmaleimide and removed via scraping in 1 ml of 100 % HBSS. Cells were centrifuged 
at 21,920 x g for 1 min and the resulting pellets were flash frozen in liquid nitrogen and 
stored at -80 °C until further use. Cell pellets were thawed on ice and 400 uL of solubilizing 
buffer [50 mM Tris (pH 7.5), 1% Nonidet P-40, 2 mM EDTA, 100 mM NaCl, 50 mM 
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MgCl2, 10 mM N-ethylmaleimide and 1X Protease inhibitor cocktail (Promega)] was added 
to each sample. The cell pellet was resuspended using a pipet and all clumps were dispersed 
using a 20 G needle followed by incubation on a rotator for 2 h at 4 °C. Cellular debris and 
nuclei was pelleted using a refrigerated Eppendorf microcentrifuge at 21,920 x g at 4 °C for 
10 min. The supernatant was transferred to a fresh tube and the amount of protein was 
quantified using the BCA method as described in Section 2.6.1.  
Three hundred micrograms of cell lysate was transferred to a new tube and combined 
with 10 g of affinity-purified rabbit anti-Xenopus HSP30 antibody or 15 g of monoclonal 
mouse anti-γ-tubulin antibody. The antibody-cell lysate mixture was incubated on a rotator 
overnight at 4 °C. One hundred micrograms of the remaining cell lysate was added to loading 
buffer [0.0625M Tris (pH 6.8), 10% (v/v) glycerol, 2% (w/v) SDS, 5% (v/v) β-
mercaptoethanol, 0.00125% (w/v) bromophenol blue] to a final concentration of 1X, boiled 
for 10 min and stored at -20 °C until further use. The following day, 100 L of Protein G 
Sepharose beads (Sigma Aldrich) per sample were washed with solubilizing buffer for 5 min 
at 4 °C and then spun at 1,000 x g for 1 min at 4 °C. This was repeated twice before the 
beads were placed on ice prior to incubation with the antibody-lysate mixture. 
The antibody-lysate mixture was added to the 100 L of beads and incubated on the 
rotator at 4 °C for 2 h. After 2 h of incubation, the beads were spun at 1,000 x g for 1 min at 
4 °C. The supernatant was removed and 200 L of the supernatant was added to loading 
buffer and marked as “Flow Through”. The beads were then rinsed 3 times with solubilizing 
buffer for 5 min at 4 °C. Finally, the beads were resuspended in 100 L of loading buffer and 
boiled for 10 min and kept at –20 °C until further use. The samples were then 
electrophoresed be means of SDS-PAGE and proteins were transferred onto a nitrocellulose 
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membrane. Immunoblot analysis utilized polyclonal rabbit anti-Xenopus HSP30 antibody 
(Fernando and Heikkila, 2003); 1:500 dilution, the monoclonal mouse anti-γ-tubulin antibody 
(Sigma-Aldrich); 1:1000 dilution, the polyclonal rabbit anti-BiP antibody (Sigma-Aldrich); 
1:1000 dilution and the polyclonal rabbit anti-actin antibody (Sigma-Aldrich); 1:200. 
 
2.9 Densitometry and statistical analysis 
Densitometric analyses within the range of linearity were performed using ImageJ 
(1.42q) software on all blots as described previously (Khan and Heikkila, 2011). Briefly, 
experiments were repeated in triplicate, and the average densitometric values were expressed 
as a percentage of the maximum hybridization band (for HSP30, HSP70 or HO-1) or as fold-
increase with respect to control cells (for BiP or GRP94). The data were graphed with 
standard error of the mean represented as vertical error bars. Statistical analysis through one 
way analysis of variance (ANOVA) followed by Tukey’s Multiple comparison post-test were 
performed with this data to determine if statistically significant differences existed between 
samples. Confidence levels used were 90% (p < 0.1; Δ) and 95% (p < 0.05; *). 
 
2.10 Immunocytochemistry and laser scanning confocal microscopy 
Cells were prepared for imaging by laser scanning confocal microscopy (LSCM) on 
22 x 22 mm glass coverslips in sterile petri dishes. In order to clean the glass coverslips, they 
were placed in small Coplin jars to ensure full contact with the base solution [49.5% (v/v) 
ethanol, 0.22M NaOH] for 30 min with periodic shaking at room temperature. The coverslips 
were then rinsed under running distilled water for 3 h and dried on Whatman paper. A6 cells 
were grown on flame sterilized cover slips for 24 h at 22 °C.  
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For experiments involving recovery from heat stress, the petri dishes were wrapped 
with parafilm, sealed in a plastic bag and then placed in a heated water bath set at 33 °C for 2 
h and allowed to recover at 22 °C. Cells on coverslips were heat shocked and then treated for 
the duration of the experiment with 100 µM cycloheximide after 2 h of recovery followed by 
incubation with 30 µM MG132 after 6 h in recovery. Some cells were also treated 0.5 h 
before heat shock with 10 µM SB203580 for the duration of the experiment. For the 
remaining experiments the cells were either maintained at 22 °C or treated with 7 µM 
A23187, 30 μM MG132, 2.5 μM celastrol, 5 μM withaferin A, 20 μM sodium arsenite or 100 
μM cadmium chloride for 16 h.  
Following the treatments, cells were rinsed with phosphate buffered saline [PBS; 1.37 
M NaCl, 67 mM Na2HPO4, 26 mM KCl, 14.7 mM KH2PO4, 1 mM CaCl2, 0.5 mM MgCl2, 
pH 7.4] and fixed using 3.7% (w/v) paraformaldehyde (pH 7.4 in PBS; BDH, Toronto, ON) 
for 15 min. A6 cells were rinsed 3 times with PBS for 5 min each and permeabilized using 
0.3% Triton X-100 (Sigma-Aldrich) for 10 min. A6 cells were then rinsed 3 times with PBS 
and incubated with 3.7 % (w/v) bovine serum albumin fraction V (BSA; Fischer Scientific) 
for 1 h or overnight on the shaker at 4 °C. The BSA fraction V was filter-sterilized using a 
0.45 μm filter (Pall Filtration Corp., St. Laurent, QC) to remove debris that might negatively 
affect the imaging.  
The following day cells were incubated with affinity-purified rabbit anti-Xenopus 
HSP30 antibody (1:500), affinity-purified rabbit anti-BiP antibody (1:1000; Sigma Aldrich), 
monoclonal mouse anti-PABP antibody (1:100; Novus Biologicals, Littleton, CO), affinity-
purified rabbit anti-TIA1 antibody (1:100; Cedarlane), monoclonal mouse anti-γ-tubulin 
antibody (1:100; Sigma Aldrich) or monoclonal mouse anti-vimentin antibody (1:50; Dako 
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Canada Ltd., Burlington, ON) in 3.7 % BSA for 1h. Following three washes with PBS, 
indirect labeling of A6 cells was performed using fluorescent-conjugated secondary 
antibodies including goat anti-rabbit Alexa Fluor 488 (Invitrogen Molecular Probes, 
Carlsbad, CA) at 1:2000, or goat anti-mouse Alexa Fluor 488 (Invitrogen Molecular Probes) 
at 1:1000 or goast anti-mouse Alexa Fluor 555 (Invitrogen Molecular Probes) at 1:1000 in 
3.7 % BSA for 30 min in the dark. To visualize the actin cytoskeleton, A6 cells were 
incubated with rhodamine-tetramethylrhodamine-5-isothiocyanate phalloidin (TRITC; 
Invitrogen Molecular Probes) for 15 min at 1:100 in 3.7 % BSA in the dark. A ProteoStat 
aggresome detection kit (Enzo Life Sciences, Plymouth Meeting, PA) was used to monitor 
the presence of aggresome-like structures as per manufacturer’s instructions. The cover slips 
were dried and mounted on glass slides with Vectashield mounting medium containing 4, 6-
diamidino-2-phenylindole (DAPI; Vector Laboratories Inc., Burlingame, CA) to stain nuclei. 
Coverslips were permanently attached to glass slides by using clear nail polish and examined 
by laser scanning confocal microscopy by using a Zeiss Axiovert 200 microscope and ZEN 
2009 software (Carl Zeiss Canada Ltd., Mississauga, ON). 
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Chapter 3: Results 
3.1 Distinct patterns of HSP30 and HSP70 degradation in cells recovering from heat 
stress 
3.1.1 Elevated levels of HSP30 in A6 cells recovering from thermal stress 
Preliminary experiments compared the effect of elevated temperatures on HSP30 and 
HSP70 accumulation in X. laevis A6 cells. Cells incubated at elevated temperatures of 33 or 
35 °C resulted in enhanced accumulation of both HSP30 and HSP70 in comparison to cells 
maintained at 22 °C (Fig. 7). Actin levels remained constant throughout these treatments. I 
then compared the relative levels of HSP30 and HSP70 in Xenopus laevis A6 kidney 
epithelial cells at different time periods during recovery from a heat shock. Immunoblot 
analysis revealed that after a 2 h heat shock treatment at 33 °C, the relative levels of HSP30 
accumulation during recovery at 22 °C increased to peak levels at 8 h and then declined to 
81% after 24 h and to 67% and 21% after 48 and 72 h of recovery, respectively (Fig. 8). In 
other immunoblot experiments, HSP30 was still detectable after 96 h of recovery (data not 
shown). In contrast, the relative levels of HSP70 peaked 2 h after recovery from heat shock 
and then declined to 71% by 8h, 26% at 24 h and only 5% and 2% at 48 and 72 h, 
respectively. In these experiments the relative levels of actin were not affected as indicated 
by densitometric analyses (data not shown). 
 
3.1.2 Pattern of hsp30 and hsp70 mRNA decay during recovery from heat shock 
Given the extended pattern of decay in the relative levels of HSP30 compared to 
HSP70, northern blot analysis was performed to determine if they reflected the relative levels   
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Figure 7. HSP30, HSP70 and actin accumulation in A6 cells subjected to heat shock. 
Cells were maintained at 22 °C or treated at 33 °C or 35 °C for 2 h followed by a 2 h 
recovery at 22 °C. After treatment, cells were harvested and total protein was isolated. 
Twenty μg of protein was then resolved on a 12% SDS-polyacrylamide gel. Protein was 
transferred to nitrocellulose membranes and probed with anti-HSP30, anti-HSP70 or anti-
actin polyclonal antibodies as described in Material and methods. These data are 
representative of three separate experiments.  
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Figure 8. Relative levels of HSP30 and HSP70 accumulation in cells recovering from 
heat shock. A) Cells were maintained at 22 °C (C) or incubated at 33 °C for 2 h and 
subsequently allowed to recover at 22 °C for different time intervals ranging from 0 to 72 h. 
Total protein was isolated and 40 µg was subjected to immunoblot analysis using anti-
HSP30, anti-HSP70 or anti-actin polyclonal antibodies as described in Materials and 
methods. These data are representative of three separate experiments. B) Image J software 
was used to perform densitometric analysis of signal intensity for HSP30 (black) and HSP70 
(white) protein bands as described in Materials and methods. The data are expressed as a 
percentage of the maximum band (33 °C with 8 h recovery for HSP30 and 33 °C with 2 h 
recovery for HSP70) while the standard errors are represented by vertical error bars. 
Statistical Analysis was performed as described in Materials and methods.  
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of their mRNAs. As shown in Figure 9, maximum levels of hsp30 and hsp70 mRNA 
accumulation occurred at 33 °C with no recovery. The relative levels of both hsp30 and 
hsp70 mRNA then declined in a similar fashion after 2 to 24 h of recovery with no detectable 
levels of either mRNA after 48 h of recovery at 22 °C. The relative levels of eIf1α mRNA 
were relatively consistent during the recovery period. 
 
3.1.3 Effect of cycloheximide on HSP30 and HSP70 accumulation in cells recovering 
from thermal stress 
The next phase of this study examined the effect of the translational inhibitor, 
cycloheximide, on the pattern of HSP30 and HSP70 decay during recovery from heat shock 
using immunoblot analysis. As shown in Figure 10, cells pretreated with 100 µM 
cycloheximide for 2 h before a 33 °C heat shock completely inhibited the accumulation of 
HSP30 and HSP70. Given these results, cells were treated with this concentration of 
cycloheximide immediately after the cells were transferred from 33 to 22 °C for up to 36 h of 
recovery. Maximum HSP30 and HSP70 accumulation occurred in cells with no recovery. 
After 2 h of recovery the relative levels of HSP30 dropped to 85% compared to cells with no 
recovery. This relative level of HSP30 was maintained at 8 h followed by a drop to 61% at 
both 16 and 24 h with a slight reduction to 57% after 36 h of recovery. In contrast, HSP70 
levels displayed a faster decay during recovery from heat shock than HSP30. Compared to 
peak levels, HSP70 was reduced to 25% after 8 h and 4% after 16 h of recovery. HSP70 was 
not detected in samples after 24 or 36 h of recovery. Also, the relative levels of actin were 
unchanged throughout this experiment. Given the prolonged elevation of HSP30 during 
recovery in the presence of cycloheximide, the localization of HSP30 was examined by   
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Figure 9. Hsp30, hsp70 and eIF1α mRNA accumulation in cells recovering from heat 
stress. A) A6 cells were maintained at 22 °C (C) or incubated at 33 °C for 2 h and 
subsequently allowed to recover at 22 °C from 0 to 72 h. Cells were harvested and total RNA 
was isolated and quantified as described in Materials and methods. Ten µg of total RNA was 
analyzed by northern hybridization analysis using hsp30, hsp70 and eIF1α antisense 
riboprobes. These data are representative of three separate experiments. B) Image J software 
was used to perform densitometric analysis of signal intensity of hsp30 (black) and hsp70 
(white) mRNA bands as described in Materials and methods. The data are expressed as a 
percentage of the maximum band (33 °C with no recovery for either hsp30 or hsp70) while 
the standard errors are represented by vertical error bars.  
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Figure 10. Effect of cycloheximide on the relative levels of HSP30 and HSP70 in A6 cells 
recovering from heat stress. A) Cells were maintained at 22 °C (C) or treated with 100 µM 
cycloheximide (CHX) for 2 h prior to incubation at 33 °C for 2 h plus a 2 h recovery (H) or 
incubated at 33 °C for 2 h followed by the immediate addition of cycloheximide to a final 
concentration of 100 µM and then incubated at 22 °C for different time intervals ranging 
from 0 to 36 h. Cells were harvested and total protein was isolated and analyzed by 
immunoblotting using anti-HSP30, anti-HSP70 or anti-actin polyclonal antibodies as 
described in Materials and methods. These data are representative of three separate 
experiments. B) Image J software was used to perform densitometric analysis of signal 
intensity for HSP30 (black) and HSP70 (white) protein bands as described in Materials and 
methods. The data are expressed as a percentage of the maximum band (33 °C with no 
recovery for HSP30 and HSP70). The standard errors are represented by vertical error bars.  
 
  
 70 
 
 
 71 
immunocytochemistry (Fig. 11). As shown in Figure 11A, immunocytochemistry did not 
detect the presence of HSP30 in control or in cells pretreated with cycloheximide prior to 
heat shock in contrast to cells treated at 33 °C for 2 h. In cells recovering from heat stress, 
HSP30 occurred in 90 percent of cells in a granular pattern after 8 h of recovery and stayed 
elevated up to 36 h after recovery. Additionally, cells treated with cycloheximide during 
recovery from the 33 °C treatment also showed HSP30 accumulation in 60 percent of cells 
primarily in the cytoplasm in a granular pattern (Fig. 11C). This accumulation pattern was 
observed in cells recovering up to 36 h. Unfortunately, HSP70 was not examined because the 
affinity-purified, polyclonal anti-HSP70 antibody, which was utilized successfully in 
immunoblot analysis, was unable to specifically detect HSP70 by immunocytochemistry 
(Gauley et al., 2008). Examination of the F-actin cytoskeleton revealed the presence of 
membrane ruffling in cells recovering from heat shock and after the addition of 
cycloheximide. This phenomenon was detectable in cells after 2 h of recovery and appeared 
to peak at 8 h with less ruffling of the cytoskeleton at 24 h followed by a more control-like 
appearance of the cytoskeleton after 36 h. 
 
3.1.4  Effect of cycloheximide and MG132 on HSP30 and HSP70 accumulation in cells 
recovering from thermal stress 
The eukaryotic proteasome, which is involved in the degradation of most proteins in 
the cell, can be reversibly inhibited by MG132. To determine if proteasomal inhibition 
affected the degradation of HSP30 and HSP70, A6 cells were treated with MG132 in 
addition to cycloheximide as shown in Figure 12. In these experiments, cells were heat 
shocked at 33 °C and then allowed to recover in the presence of cycloheximide at 22 °C   
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Figure 11. Localization of heat shock-induced HSP30 in cells during recovery with or 
without cycloheximide. A) Cells were cultured on base-washed coverslips and maintained at 
22 °C (Control) or treated at 33 °C with or without a 2 h pretreatment of 100 µM 
cycloheximide. B & C) Cells were also incubated at 33 °C for 2 h and then allowed to 
recover at 22 °C for 2, 8, 24 or 36 h with (panel C) or without (panel B) 100 µM 
cycloheximide. Actin and nuclei were stained directly with phalloidin conjugated to TRITC 
(red) and DAPI (blue), respectively. HSP30 was indirectly detected with an anti-HSP30 
antibody and a secondary antibody conjugated to Alexa-488 (green). From left to right, the 
columns display fluorescence detection channels for actin, HSP30 and merger of actin, DAPI 
and HSP30. White arrows indicate membrane ruffling of the F-actin cytoskeleton. The 20 µm 
white scale bars are indicated at the bottom right section of each panel. These results are 
representative of 3 separate experiments. 
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Figure 12. Effect of cycloheximide or cycloheximide plus MG132 on HSP30 and HSP70 
levels in A6 cells recovering from heat shock. A) Cells were maintained at 22 °C (C1) or 
treated with 100 µM cycloheximide (CHX) at 22 °C for 6 h prior to the addition of MG132 
to a final concentration of 30 µM for 36 h at 22 °C (C2). Some cells were heat shocked at 33 
°C for 2 h followed by recovery for up to 36 h at 22 °C in the presence of 100 µM 
cycloheximide with the addition of MG132 to a final concentration of 30 µM at the 6 h time 
point. Cells were harvested and total protein was analyzed by immunoblotting using anti-
HSP30, anti-HSP70 or anti-actin polyclonal antibodies as described in Materials and 
methods. These data are representative of three separate experiments. B) Image J software 
was used to perform densitometric analysis of signal intensity for HSP30 (black) and HSP70 
(white) protein bands as described in Materials and methods. The data are expressed as a 
percentage of the maximum band (33 °C with no recovery for HSP30 and HSP70). The 
standard errors are represented by vertical error bars. 
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followed by the addition of MG132 after 6 h of recovery. Immunoblot analysis revealed that 
maximum levels of HSP30 and HSP70 occurred in cells subjected to heat stress with no 
recovery. After 16 h of recovery from heat shock in the presence of cycloheximide and 
MG132, the relative levels of both HSP30 and HSP70 were approximately 64 and 61% of the 
maximum values, respectively. Thereafter, the relative level of HSP30 after 36 h of recovery 
was 57% while HSP70 was reduced to 33% of maximum value. In control experiments, cells 
that were incubated at 22 °C (C1) or pretreated with cycloheximide at 22 °C for 6 h and then 
treated with MG132 for 36 h (C2) showed no detectable levels of HSP30 or HSP70. 
Immunocytochemical analysis determined that cells pretreated with cycloheximide 
and then incubated with MG132 displayed no HSP30 accumulation (Fig. 13). In cells 
recovering from heat shock, treatment with cycloheximide and MG132 revealed the 
continued presence of HSP30 in a granular pattern in over 60% of the cells after 36 h. 
Finally, examination of the F-actin organization revealed a disorganized cytoskeleton with 
ruffled edges in cells recovering in cycloheximide and MG132 for 8 and 24 h. This F-actin 
membrane ruffling decreased over time since more control-like stress fibers were visible in 
cells recovering for 36 h (white arrows, Fig. 13). 
 
3.1.5  HSP30 stability and oligomerization during recovery from heat shock is 
regulated by p38 phosphorylation in A6 cells 
Enhanced accumulation of HSP30 during recovery from stress could be due to the 
formation of multimeric HSP30 complexes (Ohan et al., 1998; Fernando and Heikkila, 2000; 
Fernando et al., 2003) that might not be readily degraded by the proteasome. To test this, we 
used the pyridinylimidazole drug SB203580, an inhibitor of p38 phosphorylation.   
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Figure 13. Localization of heat shock-induced HSP30 in cells recovering in the presence 
of cycloheximide plus MG132. Cells were cultured on base-washed coverslips and 
maintained at 22 °C (Control) or pretreated with 100 µM cycloheximide and subsequently 
treated with 30 µM MG132 for 36 h. Cells were also incubated at 33 °C for 2 h and 
subsequently allowed to recover at 22 °C in 100 µM cycloheximide for 8, 24 or 36 h with the 
addition of 30 µM MG132 at the 6 h time point. Actin and nuclei were stained directly with 
phalloidin conjugated to TRITC (red) and DAPI (blue), respectively. HSP30 was indirectly 
detected with an anti-HSP30 antibody and a secondary antibody conjugated to Alexa-488 
(green). From left to right, the columns display fluorescence detection channels for actin, 
HSP30 and merger of actin, DAPI and HSP30. White arrows indicate ruffling of the F-actin 
cytoskeleton. The 20 µm white scale bars are indicated at the bottom right section of each 
panel. These results are representative of 3 separate experiments. 
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P38 is part of the p38 MAP kinase pathway that was found to phosphorylate Xenopus HSP30 
in vitro and resulted in the breakdown of HSP30 multimeric complexes into smaller 
oligomers (Fernando et al., 2003). In the present study, pretreatment of A6 cells with 
SB203580 resulted in enhanced accumulation of HSP30 in cells recovering from the 33 °C 
heat shock (Fig. 14A). However, p38 and actin levels did not change in response to 
SB203580 pretreatment. Additionally, in cells treated with SB203580 during recovery from 
heat shock for 8 or 24 h had decreased relative levels of phosphorylated p38 compared to 
cells without the inhibitor (Fig. 14A). Furthermore, the number of cells showing the presence 
of HSP30 increased from 25% to 90 % when cells were pretreated with SB203580 and 
allowed to recover for 8 h from a 33 °C heat treatment (Fig. 15). Similarly, only 15 % of 
cells recovering from 33 °C thermal stress for 24 h accumulated HSP30 in comparison to 90 
% of the cells that had been pretreated with SB203580.  
It was previously determined that phosphorylation of HSP30 induced the breakdown 
of multimeric structures into smaller units in vitro (Fernando et al., 2003). The presence of 
multimeric HSP30 complexes in A6 cells recovering from thermal stress was detected by 
means of native pore-exclusion limit electrophoresis followed by immunoblotting and 
immunodetection. In cells recovering from a 33 °C heat shock for 24 h, HSP30 complexes 
were detected at approximately 140 and 67 kDa (Fig. 14B). In comparison, cells pretreated 
with SB203580 and allowed to recover for 24 h after a 33 °C heat shock showed the presence 
of relatively large HSP30 complexes migrating from approximately 667 to 220 kDa 
(asterisks, Fig. 14B). As shown in Figure 16, immunocytochemical analysis revealed the 
presence of large HSP30 immunoreactivity structures (white arrows) in the cytoplasm of 
cells that had recovered from heat shock in the presence of SB203580 for 2 or 24 h compared   
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Figure 14. Effect of SB203580 on the relative levels of HSP30, p38 and phosphorylated 
p38 in cells recovering from thermal stress. A) A6 cells were incubated at 22 °C or 33 °C 
for 2 h with 2 or 24 h recovery, with (+) or without (-) SB203580 (SB) and subsequently 
treated with cycloheximide (CHX). Cells were harvested and total protein was analyzed by 
immunoblotting using anti-HSP30, anti-HSP70, anti-p38, anti-phospho p38 (p-p38) or anti-
actin polyclonal antibodies as described in Materials and methods. These results are 
representative of 3 separate experiments. B) A6 cells were incubated 22 °C or 33 °C for 2 h 
with 24 h recovery, with (+) or without (-) SB203580 (SB). Cells were harvested and total 
protein was analyzed by native pore-exclusion limit electrophoresis. This was followed by 
immunoblotting using the anti-HSP30 polyclonal antibody as described in Materials and 
methods. Approximate molecular mass in kDa are indicated on the left of the figure. 
Asterisks with arrows indicate the position of HSP30 complexes. These results are a 
representative of 4 separate experiments. 
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Figure 15. Localization of HSP30 in cells treated with SB203580 and cycloheximide 
during recovery from thermal stress. A6 cells were incubated at 22 °C or 33 °C for 2 h 
with 2 or 24 h recovery, with (+) or without (-) SB203580 (SB) and subsequently treated 
with cycloheximide (CHX). Actin and nuclei were stained directly with phalloidin 
conjugated to TRITC (red) and DAPI (blue), respectively. HSP30 was indirectly detected 
with an anti-HSP30 antibody and a secondary antibody conjugated to Alexa-488 (green). The 
20 µm white scale bars are indicated at the bottom right section of each panel. These results 
are representative of 3 separate experiments. 
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to cells not treated with the phosphorylation inhibitor. In some cells, these large structures 
surrounded HSP30 non-immunoreactive areas in the cytoplasm. In previous studies, we 
detected the presence of relatively large HSP30 immunoreactivity complexes that were 
suggested to be associated with possible aggresome-like structures (Young and Heikkila, 
2010; Khan and Heikkila, 2011). Given these findings, we employed a ProteoStat aggresome 
assay (Shen et al., 2011; Nakajima and Suzuki, 2013) to detect the presence of aggresome-
like structures in A6 cells recovering from heat shock. As shown in Figure 16, cells that had 
recovered for 2 h after heat shock displayed a relatively low level of aggresome-like 
structures, which increased in size and number in the perinuclear region when the recovery 
period was extended to 24 h. The presence of SB203580 during recovery from heat shock 
resulted in an increase in the size of these aggresome-like structures. A careful 
immunocytochemical analysis through the use of Z-stacking revealed that HSP30 enveloped 
some of these aggresome-like structures as well as occurring within them. In control cells, 
aggresome-like structures were not detected (data not shown). 
 
3.2 Proteasome inhibitors induce cytosolic and ER molecular chaperones 
3.2.1 Effect of celastrol, withaferin A, MG132 and A23187 on ubiquitinated protein 
accumulation and inhibition of chymotrypsin-like activity  
In the previous section, an association of HSP30 with aggresome-like structures 
during recovery from heat shock was detected. Since aggresomes are produced in response to 
proteasomal inhibition, I examined in detail the effect of various proteasomal inhibitors on 
the relative levels of cytoplasmic and endoplasmic reticulum chaperone levels in the Xenopus 
A6 cell line. Initial experiments were performed to examine the effect of 3 proteasomal   
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Figure 16. Association of HSP30 multimeric complexes with aggresome-like structures 
in cells recovering from heat stress. A6 cells were incubated at 33 °C for 2 h with 2 or 24 h 
recovery, with (+) or without (−) SB203580 (SB). ProteoStat aggresome detection kit was 
used to directly stain aggresome-like structures and nuclei were stained directly DAPI (blue). 
HSP30 was detected indirectly with an anti- HSP30 antibody and a secondary antibody 
conjugated to Alexa-488 (green). From left to right, the columns display fluorescence 
detection channels for HSP30, ProteoStat assay, and merger of ProteoStat assay, DAPI and 
HSP30. The white arrows indicate large HSP30 immuno-reactivity structures and dense 
aggresome-like structures. In the bottom two rows, the white rectangle contains aggresome-
like structures, which are duplicated and enlarged at the bottom left corner (inset) of each 
panel. The 20 μm white scale bars are indicated at the bottom right section of each panel. 
These results are representative of 3 separate experiments. 
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inhibitors, MG132, celastrol and withaferin A on the relative levels of ubiquitinated proteins 
and proteasomal chymotrypsin (CT)-like enzyme activity. The concentrations of the 
proteasomal inhibitors employed in this study were determined previously to induce HSP30 
and HSP70 accumulation in either Xenopus A6 cells or mammalian cells (Yang et al., 2007; 
Young and Heikkila, 2010; Walcott and Heikkila, 2010). 
Immunoblot analysis revealed that relative levels of ubiquitinated proteins in cells 
treated with 2.5 µM celastrol or 5 µM withaferin A for 16 h or 30 μM MG132 for 24 h at 22 
°C were 5 to 6-fold higher than observed in control cells (Fig. 17). However, treatment of 
cells with 7 µM A23187, a calcium ionophore and activator of the unfolded protein response 
(Drummond et al., 1987; Winning et al., 1989; Li et al., 1993; Miskovic and Heikkila, 1999), 
for 24 h did not result in a significant increase in ubiquitinated protein levels (Fig. 17). 
Furthermore, treatment of cells with higher concentrations of A23187 (10 to 14 µM) did not 
result in enhanced accumulation of ubiquitinated protein relative to control (data not shown). 
Additionally, cells treated with 7 µM A23187 for 24 h, 2.5 µM celastrol for 16 h, 30 μM 
MG132 for 24 h or 5 μM withaferin A for 16 h showed a decrease in CT-like activity of 15, 
66, 82 and 65 %, respectively, as shown in Fig. 17C. 
 
3.2.2 Proteasome inhibitors induced hsp30, hsp70, bip mRNA and HSP30, HSP70, BiP 
and GRP94 accumulation in A6 cells 
The relative levels of hsp30, hsp70, bip and eIf1α mRNA, in response to treatment 
with proteasome inhibitors or A23187 was determined using Northern blot analysis. 
Previously our laboratory reported that A6 cells treated with classical proteasome inhibitors 
including MG132 and lactacystin induced hsp30 mRNA accumulation (Young and Heikkila,   
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Figure 17. Effect of A23187, celastrol, withaferin A and MG132 on relative levels of 
ubiquitinated protein and chymotrypsin-like activity. A) Cells were maintained at 22 °C, 
treated with 7 μM A23187 for 24 h (A23187), treated with 2.5 μM celastrol for 16 h (CEL), 
treated with 5 μM withaferin A for 16 h (WA) or treated with 30 μM MG132 for 24 h 
(MG132) at 22 °C. Protein was transferred to nitrocellulose membrane from SDS 
polyacrylamide gels and probed with a mouse anti-ubiquitin monoclonal antibody as 
described in Materials and methods. The positions of molecular mass standards in kDa are 
shown in the first lane (M). These data are representative of three separate experiments. B) 
Image J software was used to perform densitometric analysis of the signal intensity for 
ubiquitinated protein bands of western blot images as described in Materials and methods. 
The data are expressed as a percentage of the lane with maximum density (MG132) while the 
standard error is represented by vertical error bars. The level of significance of the 
differences between samples was calculated by one-way ANOVA with a Tukey’s post-test. 
Significant differences between the control cells and A6 cells treated with 2.5 μM celastrol 
(16 h), 5 μM withaferin A (16 h) or 30 μM MG132 (24 h), are indicated as * (p < 0.05). 
These data are representative of three separate experiments. C) Effect of A23187, celastrol, 
withaferin A or MG132 on chymotrypsin (CT)-like activity of A6 cells. Cells were 
maintained at 22 °C, treated with 7 μM A23187 for 24 h (A23187), treated with 2.5 μM 
celastrol for 16 h (CEL), treated with 5 μM withaferin A for 16 h (WA) or treated with 30 
μM MG132 for 24 h (MG132) at 22 °C. Cells were suspended in L-15 media and 15,000 
cells per well were placed in a 96-well plate. A cell-based CT-like assay was used to monitor 
the proteolytic activity as described in Materials and methods. The CT-like activity was 
measured and expressed as a percentage of the CT-like activity observed in control cells. The 
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level of significance of the differences between samples was calculated by one-way ANOVA 
with a Tukey’s post-test. Significant differences between control cells and cells treated with 
celastrol, withaferin A or MG132 are indicated as * (p < 0.05).  
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2010). In the present study, an increased accumulation of hsp30 and hsp70 mRNA was 
observed in cells treated with 2.5 µM celastrol, 5 µM withaferin A or 30 μM MG132 but not 
with A23187 when compared to control cells (Fig. 18A). Moreover, as shown in Figure 18A, 
enhanced levels of bip mRNA were detected in cells treated with 7 µM A23187, 2.5 µM 
celastrol, 5 µM withaferin A or 30 μM MG132 in comparison to control cells. Densitometric 
analysis revealed a 7-, 5-, 5- or 6-fold increase in bip mRNA levels in cells treated with 
A23187, celastrol, withaferin A or MG132, respectively (Fig. 18B). The relative levels of 
eIf1α mRNA remained unchanged throughout the course of these treatments. 
HSP30, HSP70, BiP and GRP94 protein accumulation in response to proteasome inhibitors 
or A23187 treatment of A6 cells was determined by immunoblot analysis. Treatment of A6 
cells with 2.5 µM celastrol, 5 µM withaferin A or 30 μM MG132 for 24 h resulted in 
significantly enhanced accumulation of HSP30 and HSP70 accumulation in comparison to 
control cells (Fig. 19). Treatment with 7 µM A23187 did not induce any HSP30 or HSP70 
accumulation. In comparison, 7 µM A23187 induced a 2-fold accumulation of BiP and 
GRP94. This study also determined that treatment of cells with 2.5 µM celastrol, 5 µM 
withaferin A or 30 μM MG132 for 24 h resulted in 2-, 2- and 3-fold increases in BiP 
accumulation respectively (Fig. 19). These stressors also significantly increased GRP94 
accumulation in comparison to control cells (Fig 19).  
 
3.2.3 Temporal pattern of proteasomal inhibitor-induced HSP30, HSP70, BiP and 
GRP94 accumulation 
In time course studies of A6 cells treated with 30 µM MG132 or 2.5 µM celastrol at 
22 °C, an enhanced accumulation of HSP30, HSP70, BiP and GRP94 was first detected at 8   
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Figure 18. Effect of A23187, celastrol, withaferin A and MG132 on hsp30, hsp70, bip 
and eIF1α mRNA levels. A) Cells were maintained at 22 °C or treated with 7 μM A23187 
for 24 h (A23187), 2.5 μM celastrol for 16 h (CEL), 5 μM withaferin A for 16 h (WA) or 30 
μM MG132 for 24 h (MG132) at 22 °C. Cells were harvested and total RNA was isolated. 
Total RNA (10 μg) was analyzed by Northern hybridization analysis using hsp30, hsp70, bip 
and eIF1α antisense riboprobes as described in Materials and methods. These data are 
representative of three separate experiments. B) Image J software was used to perform 
densitometric analysis of the signal intensity for hsp30 (black), hsp70 (white) and bip (grey) 
mRNA levels of northern blot images as described in Materials and methods. The data are 
expressed as a percentage of the maximum signal (30 μM MG132 for 24 h for hsp30 and 
hsp70 and 7 μM A23187 for 24 h for bip). The standard error is represented by vertical error 
bars. The level of significance of the differences between samples was calculated by one-way 
ANOVA with a Tukey’s post-test. Significant differences between the control cells and 
treated cells are indicated as * (p < 0.05). 
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Figure 19. Effect of A23187 and proteasome inhibitors on HSP30, HSP70, BiP and 
GRP94 accumulation. A) Cells were maintained at 22 °C or treated with 7 μM A23187 for 
24 h (A23187), 2.5 μM celastrol for 16 h (CEL), 5 μM withaferin A for 16 h (WA) or 30 μM 
MG132 for 24 h (MG132) at 22 °C. Cells were harvested and total protein was isolated. 
Forty μg of different protein samples were then analyzed by Western blot analysis using anti-
HSP30, anti-HSP70, anti-BiP, anti-GRP94 or anti-actin antibodies as described in Material 
and methods. These data are representative of three separate experiments. B & C) Image J 
software was used to perform densitometric analysis of the signal intensity for HSP30 (black; 
panel B), HSP70 (white; panel B), BiP (black; panel C) and GRP94 (white; panel C) protein 
bands of western blot images as described in Materials and methods. The data are expressed 
for each treatment as percentage of the maximum signal (30 μM MG132 for 24 h for HSP30 
and HSP70 accumulation; Panel B or as a ratio to control levels (for BiP and GRP94 
accumulation; Panel C). The standard error is represented by vertical error bars. The level of 
significance of the differences between samples was calculated by one-way ANOVA with a 
Tukey’s post-test. Significant differences between the control cells and treated cells are 
indicated as * (p < 0.05) or Δ (p < 0.10).  
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h (Fig. 20, 21). Thereafter, levels of HSP30 increased 5- or 3-fold in MG132 or celastrol-
treated cells, respectively, in comparison to the 8 h treatment. In contrast, the relative level of 
HSP70 was elevated 20-fold, while BiP levels increased only 2- to 2.5-fold in cells treated 
with MG132 or celastrol for 24 h (Fig. 20, 21). MG132 and celastrol treatments also 
significantly increased GRP94 accumulation in A6 cells, while actin levels remained 
constant. Similar results for HSP30 accumulation were observed in cells treated with 5 μM 
withaferin A (Fig. 22). Significantly enhanced accumulation was initially observed in cells 
treated for 8 h and increased 3-fold in cells treated for 24 h. In contrast, a slightly different 
temporal phenomenon with respect to HSP70 and BiP accumulation was found for cells 
treated with 5 μM withaferin A. Withaferin A induced only a 1.5-fold increase in HSP70 
accumulation at 24 h compared to cells treated with withaferin A for 8 h (Fig 22). 
Additionally, significantly enhanced accumulation (1.5-fold) in BiP levels were not observed 
in cells until 16 or 24 h of withaferin A treatment (Fig. 22). However, similar to celastrol, 
MG132 and WA also induced expression of GRP94 to significantly higher levels compared 
to control cells. Actin levels were not affected by these treatments. 
 
3.2.4 Intracellular localization and accumulation of HSP30 and BiP in proteasome 
inhibited A6 cells 
As shown in Figures 23 and 24, the intracellular localization of HSP30 and BiP was 
examined in cells treated with A23187, MG132, celastrol or withaferin A using 
immunocytochemistry and laser scanning confocal microscopy (LSCM). Comparable studies 
with HSP70 or GRP94 were not carried out since these antibodies were unable to specifically 
detect HSP70 or GRP94 by immunocytochemistry, even though they easily detected these   
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Figure 20. Temporal pattern of MG132-induced HSP30, HSP70, BiP and GRP94 
accumulation. A) Cells were maintained at 22 °C or exposed to 30 μM MG132 for time 
intervals ranging from 2 to 24 h. Cells were harvested and total protein was isolated. The 
different protein samples were then analyzed by immunoblot analysis. These data are 
representative of three separate experiments. B & C) Image J software was used to perform 
densitometric analysis of the signal intensity for HSP30 (black; panel B), HSP70 (white; 
panel B), BiP (black; panel C), GRP94 (white; panel c) protein bands of western blot images 
as described in Materials and methods. The data are expressed for each treatment as a 
percentage of the maximum band (30 μM MG132 for 24 h for HSP30 and HSP70 
accumulation) or as a ratio to control levels (for BiP and GRP94 accumulation). The standard 
error is represented by vertical error bars. The level of significance of the differences 
between samples was calculated by one-way ANOVA with a Tukey’s post-test. Significant 
differences between the control cells and MG132-treated cells are indicated as * (p < 0.05) or 
Δ (p < 0.10).  
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Figure 21. Time course of celastrol-induced HSP30, HSP70, BiP and GRP94 
accumulation. A) Cells were maintained at 22 °C or exposed to 2.5 μM celastrol for time 
intervals ranging from 2 to 24 h at 22 °C. Cells were harvested and total protein was isolated 
and then analyzed by immunoblot analysis. These data are representative of three separate 
experiments. B & C) Image J software was used to perform densitometric analysis of the 
signal intensity for HSP30 (black; panel B), HSP70 (white; panel B), BiP (black; panel C) or 
GRP94 (white; panel C) protein bands of western blot images as described in Materials and 
methods. The data are expressed as percentage of the maximum signal (2.5 μM celastrol for 
24 h for HSP30 or HSP70 accumulation) or as a ratio to control levels (for BiP and GRP94 
accumulation). The standard error is represented by vertical error bars. The level of 
significance of the differences between samples was calculated by one-way ANOVA with a 
Tukey’s post-test. Significant differences between the control cells and celastrol-treated cells 
are indicated as * (p < 0.05) or Δ (p < 0.10).  
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Figure 22. Time course of withaferin A-induced HSP30, HSP70, BiP and GRP94 
accumulation. A) Cells were maintained at 22 °C or exposed to 5 μM withaferin A for time 
intervals ranging from 2 to 24 h at 22 °C. Cells were harvested and total protein was isolated 
and then analyzed by immunoblot analysis. These data are representative of three separate 
experiments. B) Image J software was used to perform densitometric analysis of the signal 
intensity for HSP30 (black; panel B), HSP70 (white; panel B), BiP (black; panel C) and 
GRP94 (white; panel C) protein bands of western blot images as described in Materials and 
methods. The data are expressed as percentage of the maximum signal (5 μM withaferin A 
for 24 h for HSP30 and HSP70) or as a ratio to control levels (for BiP and GRP94 
accumulation). The standard error is represented by vertical error bars. The level of 
significance of the differences between samples was calculated by one-way ANOVA with a 
Tukey’s post-test. Significant differences between the control cells and withaferin A-treated 
cells are indicated as * (p < 0.05) or Δ (p < 0.10). 
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chaperones in immunoblot analyses. Cells treated with 30 µM MG132 for 24 h, 2.5 µM 
celastrol for 8 h or 5 µM withaferin A for 16 h at 22 °C resulted in the localization of HSP30 
in the cytoplasm in a granular or punctuate pattern. HSP30 was not detectable in control cells 
maintained at 22 °C or cells treated with 7 µM A23187 for 24 h (Fig. 23). In comparison, A6 
cells maintained at 22 °C displayed BiP localization diffusely throughout the cytoplasm (Fig. 
24). Cells treated with 7 µM A23187, 30 µM MG132 for 24 h, 2.5 µM or 5 µM withaferin A 
for 16 h at 22 °C resulted in enhanced accumulation of BiP primarily in the cytoplasm in a 
punctate pattern and occasionally at the periphery of the cell membrane in comparison to 
control cells. Additionally, in withaferin A-treated cells relatively large BiP staining 
structures were found at the periphery of the nucleus in comparison to cells treated with 
A23187, which demonstrated intense BiP staining in the perinuclear region. Examination of 
general morphology and F-actin organization revealed that cells exposed to A23187, MG132 
or withaferin A displayed intact cytoskeleton and visible actin stress fibers, similar to control 
cells. However, cells treated with 2.5 µM celastrol for 8 h displayed a collapse of the 
cytoskeleton in most cells while BiP accumulation was found diffusely throughout the 
cytoplasm with enhanced levels toward the periphery of the cell. 
 
3.2.5 Withaferin A and celastrol induce heme oxygenase-1 (HO-1) accumulation in a 
time and concentration dependent manner 
 In an ancillary study, stress-induced HSP30 accumulation in A6 cells was also 
compared with the accumulation of the stress-induced enzyme, heme oxygenase-1 (HO-1). 
HO-1 is involved in heme catabolism into biliverdin which is then further converted to   
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Figure 23. Intracellular localization of HSP30 in response to proteasome inhibition. 
Cells were grown on glass coverslips and were maintained at 22 °C or treated with 7 μM 
A23187 or 30 μM MG132 for 24 h, 2.5 μM celastrol (CEL) for 8 h or 5 μM withaferin A 
(WA) for 16 h at 22 °C. Actin and nuclei were stained directly with phalloidin conjugated to 
TRITC (red) and DAPI (blue), respectively. HSP30 was indirectly detected with an anti-
Xenopus HSP30 antibody and a secondary antibody conjugated to Alexa-488 (green). From 
left to right the columns display fluorescence detection channels for actin, BiP and merger of 
actin, DAPI and BiP. The 20-μm white scale bars are indicated at the bottom right section of 
each panel. These results are representative of 3 different experiments. 
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Figure 24. Intracellular localization of BiP in response to proteasome inhibition. Cells 
were grown on glass coverslips and were maintained at 22 °C or treated with 7 μM A23187 
or 30 μM MG132 for 24 h, 2.5 μM celastrol (CEL) for 8 h or 5 μM withaferin A (WA) for 16 
h at 22 °C. Actin and nuclei were stained directly with phalloidin conjugated to TRITC (red) 
and DAPI (blue), respectively. BiP was indirectly detected with an anti-BiP antibody and a 
secondary antibody conjugated to Alexa-488 (green). From left to right the columns display 
fluorescence detection channels for actin, BiP and merger of actin, DAPI and BiP. The white 
arrows indicate perinuclear localization while the yellow areas show the presence of BiP near 
the cell membrane. The 20-μm white scale bars are indicated at the bottom right section of 
each panel. These results are representative of 3 different experiments. 
 
  
 108 
 
 109 
bilirubin, an antioxidant (Par et al., 2010). Also, HO-1 was strongly induced by reactive 
oxygen species as well as proteasomal inhibitors such as MG132, lactacystin and bortezomib 
(Lee et al., 1996; Wu et al., 2004; Kastle et al., 2012; Furfano et al. 2014). Anti-human HO-1 
antibody (Enzo Life Sciences) employed in this part of the study was created from a human 
peptide that has 100 % amino acid sequence identity with the comparable region in Xenopus 
HO-1. Cells treated with withaferin A and celastrol showed concentration- and time-
dependent increases in HO-1 and HSP30 accumulation (Fig. 25, 26). As shown in Figure 25, 
immunoblot analysis of cells treated for 24 h demonstrated HO-1 accumulation occurred 
initially in cells treated with 1 M withaferin A (Fig. 25A). In contrast, HSP30 accumulation 
was detected in cells treated with 2.5 M withaferin A. However, maximum accumulation 
was observed in cells treated with 5 M withaferin A for both HO-1 and HSP30 (Fig. 25B). 
In time course studies, HO-1 and HSP30 accumulation was initially detected in cells treated 
with 5 M withaferin A for 8 h (Fig. 25C). Maximum levels of HO-1 were observed in cells 
treated with 5 M withaferin A for 16 h while the maximum level of HSP30 was observed at 
24 h (Fig. 25D). Densitometric analysis revealed a 100-fold increase in HO-1 levels occurred 
in cells treated with 5 M withaferin A for 16 h in comparison to cells treated for only 8 h 
(Fig. 25D).  Similarly, celastrol also induced concentration and time-dependent increases in 
HO-1 and HSP30 accumulation (Fig. 26). HO-1 accumulation was first detectable in cells 
treated with 1 M celastrol while maximal levels occurred with 2.5 M celastrol (Fig. 26A). 
In comparison, HSP30 accumulation was initially observed in cells treated with a higher 
concentration of 2.5 M celastrol while maximal accumulation occurred in cells treated with 
5 M celastrol (Fig. 26A). In time course studies, celastrol-induced HO-1 and HSP30 
accumulation occurred initially in cells treated with 2.5 M celastrol for 8 h and maximal   
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Figure 25. Withaferin A-induced HO-1 and HSP30 accumulation occurs in a 
concentration- and time-dependent manner. A) Cells were maintained at 22 °C (C) or 
treated with 1, 2.5, 5 or 10 M withaferin A for 24 h at 22 °C. Cells were harvested and total 
protein was isolated. Forty μg of different protein samples were then analyzed by Western 
blot analysis using anti-HO-1, anti-HSP30 or anti-actin antibodies as described in Material 
and methods. These data are representative of three separate experiments. B) Image J 
software was used to perform densitometric analysis of the signal intensity for HO-1 (black) 
or HSP30 (white) protein bands of western blot images as described in Materials and 
methods. The data are expressed as percentage of the maximum signal (5 μM WA for 24 h 
for HO-1 and HSP30). C) Cells were maintained at 22 °C (C) or treated with 5 M 
withaferin A (WA) for 2 to 24 h at 22 °C. Cells were harvested and total protein was isolated. 
Forty μg of different protein samples were then analyzed by Western blot analysis using anti-
HO-1, anti-HSP30 or anti-actin antibodies as described in Material and methods. These data 
are representative of three separate experiments. D) Image J software was used to perform 
densitometric analysis of the signal intensity for HO-1 (black) or HSP30 (white) protein 
bands of western blot images as described in Materials and methods. The data are expressed 
as percentage of the maximum signal (5 μM WA for 16 h for HO-1 or 5 μM WA for 24 h for 
HSP30). The standard error is represented by vertical error bars. The level of significance of 
the differences between samples was calculated by one-way ANOVA with a Tukey’s post-
test. Significant differences between the control cells and withaferin A-treated cells are 
indicated as * (p < 0.05).  
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Figure 26. Concentration- and time-dependent HO-1 and HSP30 accumulation in A6 
cells treated with celastrol. A) Cells were maintained at 22 °C (C) or treated with 1, 2.5, 5 
or 7.5 M celastrol for 24 h at 22 °C. Cells were harvested and total protein was isolated. 
Forty μg of different protein samples were then analyzed by Western blot analysis using anti-
HO-1, anti-HSP30 or anti-actin antibodies as described in Material and methods. These data 
are representative of three separate experiments. B) Image J software was used to perform 
densitometric analysis of the signal intensity for HO-1 (black) or HSP30 (white) protein 
bands of western blot images as described in Materials and methods. The data are expressed 
as percentage of the maximum signal (2.5 μM celastrol for 24 h for HO-1 and 5 μM celastrol 
for 24 h for HSP30). C) Cells were maintained at 22 °C (C) or treated with 2.5 M celastrol 
for 2 to 24 h at 22 °C. Cells were harvested and total protein was isolated. Forty μg of 
different protein samples were then analyzed by Western blot analysis using anti-HO-1, anti-
HSP30 or anti-actin antibodies as described in Material and methods. These data are 
representative of three separate experiments. D) Image J software was used to perform 
densitometric analysis of the signal intensity for HO-1 (black) or HSP30 (white) protein 
bands of western blot images as described in Materials and methods. The data are expressed 
as percentage of the maximum signal (2.5 μM celastrol for 24 h for HO-1 and HSP30). The 
standard error is represented by vertical error bars. The level of significance of the 
differences between samples was calculated by one-way ANOVA with a Tukey’s post-test. 
Significant differences between the control cells and celastrol-treated cells are indicated as * 
(p < 0.05).   
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levels were observed in cells treated for 24 h (Fig. 26C). A 20-fold increase in HO-1 
accumulation was observed in cells treated for 8 h in comparison for 16 h. This was greater 
than the 4-fold increase observed with HSP30 during the same time period (Fig. 26D). 
 Immunocytochemistry and laser scanning confocal microscopy revealed that HO-1 
accumulation primarily occurred in the cytoplasm in a diffuse and granular pattern (Fig. 27). 
As seen in Figure 27, MG132-, celastrol- and withaferin A-induced HO-1 accumulation 
occurred in over 90 % of cells. Some actin re-organization to the periphery was present in 
cells treated with celastrol and withaferin A.  
 
3.3 MG132, withaferin A, sodium arsenite and cadmium chloride treatment results 
in stress granule, aggresome and large HSP30 multimeric structure formation in A6 
cells 
3.3.1 Proteasome inhibition, sodium arsenite and cadmium chloride induce large 
HSP30 multimeric complexes 
In the present study and in previous reports from our laboratory, we observed the 
presence of large HSP30 staining structures in withaferin A, MG132, sodium arsenite or 
cadmium chloride treated cells (Wolffson and Heikkila, 2009; Walcott and Heikkila, 2010; 
Young and Heikkila, 2010). MG132, celastrol and withaferin A treatments induced large 
HSP30 staining structures as highlighted by white rectangular boxes in Figure 28. Similarly, 
treatments with sodium arsenite and cadmium chloride also induced these large HSP30 
staining structures in the perinuclear region (Fig. 28B). Actin re-organization and ruffling at 
the periphery of the cells were also observed in some of these treatments. Given these 
findings, it was possible that stress-induced HSP30 may have associated with other stress-   
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Figure 27. Intracellular localization of HO-1 in response to proteasome inhibition. Cells 
were grown on glass coverslips and were maintained at 22 °C or treated with 30 μM MG132 
for 16 h, 2.5 μM celastrol (celastrol) for 16 h or 5 μM withaferin A (WA) for 16 h at 22 °C. 
Actin and nuclei were stained directly with phalloidin conjugated to TRITC (red) and DAPI 
(blue), respectively. HO-1 was indirectly detected with an anti-HO-1 antibody and a 
secondary antibody conjugated to Alexa-488 (green). From left to right the columns display 
fluorescence detection channels for actin, HO-1 and merger of actin, DAPI and HO-1. The 
20-μm white scale bars are indicated at the bottom right section of each panel. These results 
are representative of 3 different experiments. 
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Figure 28. Intracellular localization of HSP30 and presence of large HSP30 structures 
in response to proteasome inhibition. A) Cells were grown on glass coverslips and were 
maintained at 22 °C or treated with 30 μM MG132 for 16 h, 2.5 μM celastrol (celastrol) for 
16 h or 5 μM withaferin A (WA) for 16 h at 22 °C. B) Cells were also treated with 20 μM 
sodium arsenite (NA) for 16 h or 100 μM cadmium chloride (CdCl2) for 16 h at 22 °C. Actin 
and nuclei were stained directly with phalloidin conjugated to TRITC (red) and DAPI (blue), 
respectively. HSP30 was indirectly detected with an anti-HSP30 antibody and a secondary 
antibody conjugated to Alexa-488 (green). From left to right the columns display 
fluorescence detection channels for actin, HSP30 and merger of actin, DAPI and HSP30. The 
20-μm white scale bars are indicated at the bottom right section of each panel. Large HSP30 
staining structures are delineated with a white box and shown as a figure inset. These results 
are representative of 3 different experiments. 
 
  
 118 
 
 
 
 119 
 
 
 
  
 120 
inducible structures such RNA stress granules or aggresomes. 
 
3.3.2 MG132, withaferin A, sodium arsenite and cadmium chloride induce stress 
granule formation in A6 cells 
Stress granules are RNA-protein complexes composed of stalled pre-initiated mRNA 
bound to 40S ribosomal subunit, poly(A)-binding protein (PABP) and various eukaryotic 
protein synthesis elongation factors (Anderson and Kedersha, 2006). Previous studies in 
mammalian systems have shown a possible association of hsp27 with heat shock-induced 
stress granules (Kedersha et al., 2005). In this study, the presence of stress granules in A6 
cells was determined by immunocytochemistry employing antibodies that react with TIA1 
and PABP, which are marker proteins for stress granules. As shown in Figure 29, 
immunocytochemical analysis and laser scanning confocal microscopy revealed the presence 
of stress granules in A6 cells treated with either MG132 or sodium arsenite but not with heat 
shock. A6 cells treated with MG132 or sodium arsenite displayed an increase in PABP and 
TIA1 staining in the cytoplasm primarily in the perinuclear region in comparison to control 
cells. Additionally, both PABP and TIA1 co-localized in A6 cells treated with MG132 or 
sodium arsenite, confirming the presence of stress granules by two different markers. 
However, as shown in Figure 30, PABP did not co-localize with HSP30 in cells treated with 
MG132, sodium arsenite or cadmium chloride. More specifically, PABP was present in cells 
treated with MG132 in the cytoplasm in areas that had no HSP30 staining (Fig. 30B). 
Similarly, cells treated with sodium arsenite displayed no co-localization of HSP30 with 
PABP (Fig. 30C). 
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Figure 29. Presence of stress granules in cells treated with MG132 or sodium arsenite. 
Cells were grown on glass coverslips and were maintained at 22 °C (Control), incubated at 
33 °C or treated with 30 μM MG132 for 16 h or 20 μM sodium arsenite (NA) for 16 h at 22 
°C. Stress granule markers such as poly(A)-binding protein (PABP) was detected indirectly 
with an anti-PABP antibody and a secondary antibody conjugated to Alexa-555 (red). TIA1 
(granule associated RNA binding protein) was detected indirectly with an anti-TIA1 antibody 
and a secondary antibody conjugated to Alexa-488 (green). Nuclei were stained directly with 
DAPI (blue). From left to right the columns display fluorescence detection channels for 
PABP, TIA1 and merger of PABP, DAPI and TIA1. The 20-μm white scale bars are 
indicated at the bottom right section of each panel. These results are representative of 3 
different experiments. 
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Figure 30. Association of stress granules with HSP30 in cells treated with MG132, 
sodium arsenite and cadmium chloride. A) Cells were grown on glass coverslips and were 
maintained at 22 °C (Control) or treated with 30 μM MG132 for 16 h, 20 μM sodium arsenite 
(NA) for 16 h or 100 μM cadmium chloride (CdCl2) at 22 °C. The stress granule marker, 
PABP, was detected indirectly with an anti-PABP antibody and a secondary antibody 
conjugated to Alexa-555 (red). HSP30 was detected indirectly with an anti-HSP30 antibody 
and a secondary antibody conjugated to Alexa-488 (green). Nuclei were stained directly with 
DAPI (blue). From left to right the columns display fluorescence detection channels for 
PABP, HSP30 and merger of PABP, DAPI and HSP30. B & C) Magnified images of MG132 
treated cells (panel B) and sodium arsenite treated cells (panel C) are delineated with a white 
box. The 20-μm white scale bars are indicated at the bottom right section of each panel. 
These results are representative of 3 different experiments. 
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3.3.3 Formation of aggresomes in response to proteasome inhibition, arsenite or 
cadmium exposure 
Since, HSP30 did not co-localize with stress-induced RNA granules, we examined 
the possibility that HSP30 associated with stress-induced aggresomes. Aggresomes are 
specialized cellular structures containing misfolded, ubiquitinated proteins in a cage of 
intermediate filaments and cytoskeletal proteins including vimentin and γ-tubulin (Johnston 
et al., 1998). Previous studies reported that treatment of human cultured cells with 
proteasome inhibitors such as MG132 resulted in aggresome formation (Zaarur et al., 2008; 
Bolhuis & Richter-Landsberg, 2010; Xiong et al., 2013). Vimentin and γ-tubulin have been 
used as cytological markers for the presence of stress-induced aggresomes (Garcia-Mata et 
al., 1999; Bauer & Richter-Landsberg, 2006; Xiong et al., 2013). Also available is the 
ProteoStat aggresome detection kit (Enzo Life Sciences, Farmingdale, NY; Amijee et al., 
2009; Shen et al., 2011).  
In the present study, we employed anti-vimentin and anti-γ-tubulin antibodies as well 
the ProteoStat aggresome detection kit to examine the presence of stress-induced aggresomes 
in A6 cells. Cells maintained at 22 °C did not display aggresome-like structures in the 
cytoplasm as determined by the ProteoStat assay (Red channel, Fig. 31A). Additionally, in 
control cells γ-tubulin was not associated with aggresome-like structures but rather localized 
primarily in the cytoplasm and formed a mesh-like network (Fig. 31A). In comparison, cells 
incubated at 33 °C or treated with MG132 or withaferin A induced the formation of large 
putative aggresomes in the perinuclear region as detected by the ProteoStat assay (Fig. 31A). 
These putative aggresomes stained using the ProteoStat assay were also recognized by the 
anti-γ-tubulin antibody (Fig. 31A). Moreover, treatment of cells with sodium arsenite or   
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Figure 31. Treatment of cells with MG132, withaferin A, sodium arsenite or cadmium 
chloride results in the formation of aggresome-like structures. A) Cells were grown on 
glass coverslips and maintained at 22 °C (Control), incubated at 33 °C or treated with 30 μM 
MG132 for 16 h or 5 μM withaferin A (WA) for 16 h at 22 °C. B) Cells were also treated 
with 20 μM sodium arsenite (NA) for 16 h or 100 μM cadmium chloride (CdCl2) at 22 °C. 
The ProteoStat aggresome detection kit was used to directly stain aggresome-like structures 
while nuclei were stained directly with DAPI (blue). Gamma-tubulin was detected indirectly 
with an anti-γ-tubulin antibody and a secondary antibody conjugated to Alexa-488 (green). 
From left to right, the columns display fluorescence detection channels for ProteoStat assay, 
γ-tubulin and merger of ProteoStat assay, DAPI and γ-tubulin. These results are 
representative of 3 separate experiments. 
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cadmium chloride also resulted in the formation of aggresomes as detected through γ-tubulin 
and ProteoStat assay co-localization (Fig. 31B). To further confirm the presence of 
aggresome in response to MG132, withaferin A, sodium arsenite or cadmium chloride and to 
verify that the ProteoStat assay was indeed detecting aggresomes, we used an antibody 
against vimentin. As shown in Figure 32, vimentin and ProteoStat co-localized in cells 
maintained at 22 °C or treated with the selected chemical stressors. Moreover, cells treated 
with MG132 or withaferin A showed an increased number of aggresomes present in the 
perinuclear region (Fig. 32A). This phenomenon was also observed in cells treated with 
sodium arsenite or cadmium chloride (Fig. 32B). Taken together, these findings confirmed 
that treatment of A6 cells with MG132, withaferin A, sodium arsenite or cadmium chloride 
induced aggresome formation in comparison to control cells. 
 
3.3.4 HSP30 associates with aggresomes in cells treated with heat shock, MG132, 
withaferin A, sodium arsenite or cadmium chloride 
The next phase of this study was to determine whether large HSP30 staining 
structures associated with stress-induced aggresomes in A6 cells. In cells maintained at 22 
°C, neither HSP30 accumulation nor aggresomes were detected using the anti-HSP30 
antibody and the ProteoStat assay, respectively. In comparison, cells heat shocked at 33 °C 
demonstrated the presence of large HSP30 structures which co-localized with aggresomes. 
A6 cells treated with MG132 or withaferin A also displayed large HSP30 structures in the 
cytoplasm as well as the presence of aggresomes (Fig. 33A). Additionally, some large HSP30 
structures actively formed rings around the aggresomes as shown in the insets of figure 33A. 
Z-stacking revealed that HSP30 not only enveloped the aggresome but was also found  
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Figure 32. Co-localization of vimentin with aggresome-like structures in A6 cells treated 
with MG132, withaferin A, sodium arsenite or cadmium chloride. A & B) Cells were 
grown and treated as previously described in Figure 31. The ProteoStat aggresome detection 
kit (red) directly stained aggresome-like structures, while nuclei were stained with DAPI 
(blue). Vimentin was detected indirectly with an anti-vimentin antibody and a secondary 
antibody conjugated to Alexa-488 (green). From left to right, the columns display 
fluorescence detection channels for ProteoStat assay, vimentin and merger of ProteoStat 
assay, DAPI and vimentin. These results are representative of 3 separate experiments. 
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Figure 33. Association of large HSP30 structures and aggresome-like structures in 
response to MG132, withaferin A, sodium arsenite or cadmium chloride treatment. A & 
B) Cells were grown on glass coverslips and treated as described in Figure 31. The 
ProteoStat aggresome detection kit (red) directly stained aggresome-like structures. HSP30 
was detected indirectly with an anti-Xenopus HSP30 antibody and a secondary antibody 
conjugated to Alexa-488 (green). Nuclei were stained directly with DAPI (blue). From left to 
right, the columns display fluorescence detection channels for ProteoStat assay, HSP30 and 
merger of ProteoStat assay, DAPI and HSP30. Aggresomes and large HSP30 structures are 
magnified, delineated with a white box and shown as a figure inset. These results are 
representative of 3 separate experiments. 
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within the aggresome (data not shown). This phenomenon was also observed in cells treated 
with arsenite or cadmium (Fig. 33B).  
These previous results were further verified using γ-tubulin as a marker in the 
detection of aggresomes in A6 cells. As shown in Figure 34, A6 cells incubated at 33 °C 
showed enhanced HSP30 accumulation and presence of some large HSP30 structures in 
comparison to cells maintained at 22 °C. These HSP30 staining structures co-localized with 
γ-tubulin (Fig. 34A). Similarly, A6 cells treated with MG132 or withaferin A resulted in an 
increase in HSP30 accumulation in the cytoplasm as well as the appearance of aggresomes as 
shown by γ-tubulin association with these large structures (Fig. 34A). Some aggresomes co-
localized with large HSP30 structures as shown in Figure 34A insets. Again, Z-stacking 
analysis determined that the large multimeric complexes of HSP30 enveloped the aggresome 
while smaller HSP30 complexes were present within the aggresome (data not shown). 
Additionally, sodium arsenite and cadmium chloride also induced these structures and 
displayed co-localization between HSP30 and γ-tubulin (Fig. 34B). 
To further validate an association between HSP30 and γ-tubulin, co-
immunoprecipitation studies using anti-Xenopus HSP30 antibody and anti- γ-tubulin 
antibody followed by immunoblot analysis were performed. As shown in Figure 35, HSP30 
was successfully precipitated using anti-Xenopus HSP30 antibody in cells treated with 
MG132, withaferin A, sodium arsenite or cadmium chloride. Additionally, HSP30 co-
immunoprecipitated γ-tubulin and β-actin in treated cells and not in control cells (Fig. 35). In 
comparison, BiP, an ER-resident molecular chaperone did not co-immunoprecipitate with 
HSP30 in any of the treatments. To corroborate the first co-immunoprecipitation experiment, 
the procedure was repeated using the anti-γ-tubulin antibody for immunoprecipitation.   
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Figure 34. Association of large HSP30 structures and γ-tubulin in response to 
proteasome inhibition. A & B) Cells were treated as previously described in Figure 31. 
Gamma-tubulin was detected indirectly with an anti- γ-tubulin antibody and a secondary 
antibody conjugated to Alexa-555 (red). HSP30 was detected indirectly using an anti- 
Xenopus HSP30 antibody and a secondary antibody conjugated to Alexa-488 (green). Nuclei 
were stained directly with DAPI (blue). From left to right, the columns display fluorescence 
detection channels for γ-tubulin, HSP30, and merger of HSP30, DAPI and γ-tubulin. Large 
HSP30 staining structures along with areas of γ-tubulin staining are magnified, delineated 
with a white box and shown as a figure inset. These results are representative of 3 separate 
experiments. 
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Figure 35. HSP30 associates with γ-tubulin and β-actin in cells treated with MG132, 
withaferin A, sodium arsenite or cadmium chloride. Cells were maintained at 22 °C or 
treated with 30 μM MG132 for 16 h, 5 μM withaferin A (WA) for 16 h, 20 μM sodium 
arsenite (NA) for 16 h or 100 μM cadmium chloride (CdCl2) for 16 h at 22 °C. Proteins were 
isolated using non-denaturing conditions and immunoprecipitated (IP) using the anti-
Xenopus HSP30 antibody. Whole cell lysates (L), flow through (FT) and immunocomplexes 
(IC) were then analyzed by Western blot analysis using anti- Xenopus HSP30, anti-γ-tubulin, 
anti-actin or anti-BiP antibodies as described in Material and methods. These results are 
representative of 3 different experiments.  
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Western blot analysis revealed that anti-γ-tubulin antibody successfully immunoprecipitated 
γ-tubulin in control cells (Fig. 36). In contrast, no HSP30 was associated with γ-tubulin in 
control cells. Additionally, γ-tubulin and HSP30 co-immunoprecipitated in cells treated with 
MG132, withaferin A, sodium arsenite and cadmium chloride (Fig. 36). In comparison, β-
actin and BiP did not associate with γ-tubulin and were not co-immunoprecipitated in control 
or treated cells. 
 Finally, to investigate a possible association of HSP30 with vimentin, comparable 
immunocytochemical studies were performed. The vimentin antibody that worked well with 
immunocytochemistry did not recognize vimentin in immunoblot or co-immunoprecipitation 
experiments. As shown in Figure 37, treatment with MG132, withaferin A, sodium arsenite 
and cadmium chloride resulted in enhanced accumulation of HSP30 in the cytoplasm in a 
granular pattern when compared to control cells. Additionally, cells treated with MG132 or 
withaferin A showed an increased in vimentin accumulation in the perinuclear region (Fig. 
37A). Some areas of intense vimentin staining also co-localized with large HSP30 granules 
as indicated in white insets (Fig. 37A). Similar results were observed in cells treated with 
sodium arsenite and cadmium chloride when compared to control cells (Fig. 37B). 
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Figure 36. Co-immunoprecipitation of HSP30 with γ-tubulin in cells treated with 
MG132, withaferin A, sodium arsenite and cadmium chloride. Cells were maintained at 
22 °C or treated with 30 μM MG132 for 16 h, 5 μM withaferin A (WA) for 16 h, 20 μM 
sodium arsenite (NA) for 16 h or 100 μM cadmium chloride (CdCl2) for 16 h at 22 °C. 
Proteins were isolated in non-denaturing conditions and immunoprecipitated (IP) using anti 
γ-tubulin antibody as described in the Materials and methods. Whole cell lysates (L), flow 
through (FT) and immunocomplexes (IC) were then analyzed by Western blot analysis using 
anti-Xenopus HSP30, anti-γ-tubulin, anti-actin or anti-BiP antibodies as described in Material 
and methods. These results are a representation of 3 separate experiments. 
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Figure 37. Association of large HSP30 structures with vimentin in response to 
proteasome inhibition. A & B) Cells were grown on glass coverslips and were maintained 
at 22 °C (Control) or treated with 30 μM MG132 for 16 h or 5 μM withaferin A (WA) for 16 
h at 22 °C. B) Cells were also treated with 20 μM sodium arsenite (NA) or 100 μM cadmium 
chloride (CdCl2) for 16 h at 22 °C. Vimentin was detected indirectly with an anti-vimentin 
antibody and a secondary antibody conjugated to Alexa-555 (red). HSP30 was detected 
indirectly using an anti-Xenopus HSP30 antibody and a secondary antibody conjugated to 
Alexa-488 (green). Nuclei were stained directly DAPI (blue). From left to right, the columns 
display fluorescence detection channels for vimentin, HSP30, and merger of HSP30, DAPI 
and vimentin. Large HSP30 staining structures along with areas of vimentin staining are 
enlarged, delineated with a white box and shown as a figure inset. These results are 
representative of 3 separate experiments. 
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Chapter 4: Discussion 
This thesis has investigated the pattern of HSP30 accumulation in Xenopus laevis A6 
kidney epithelial cells recovering from heat stress as well as the effect of proteasomal 
inhibitors, MG132, withaferin A and celastrol on HSP30 accumulation and its possible 
association with aggresome-like structures. 
 
4.1 HSP30 degradation pattern in cells recovering from heat stress 
In initial studies examining the pattern and relative levels of HSP30 during recovery 
from heat shock, immunoblot analysis revealed that the relative levels of HSP30 declined 
gradually during recovery with elevated levels still present after 3 days. In comparison, the 
decay of heat shock-induced HSP70 during recovery occurred much faster. This prolonged 
accumulation of HSP30 during recovery from heat shock was not correlated with its mRNA 
levels since both hsp30 and hsp70 mRNA levels declined in a similar fashion with 
undetectable levels at 48 h. Additionally, incubation of A6 cells in the presence of 
cycloheximide, a translational inhibitor, displayed elevated levels of HSP30 during recovery 
from heat shock after 36 h in contrast to HSP70 levels, which declined rapidly to non-
detectable amounts at 24 h. The longer time period involved in HSP30 decay compared to 
HSP70 in A6 cells is comparable to that found with HSP27 and HSP70 in Chinese hamster 
cells (Landry et al., 1991). In this latter study HSP27 had a half-life of 13 h while the value 
for HSP70 was 4 h. A similar comparison was made with sHSPs and HSP70 in Drosophila 
Schneider S2 cells (Li and Duncan, 1995).  
In the present study, treatment of cells recovering from heat shock in the presence of 
cycloheximide plus MG132 did not have a marked effect on the relative levels of HSP30 
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compared to cycloheximide alone. Given these results, it raises the possibility that the UPS 
may not have a major role in the degradation of HSP30 as this treatment should have 
increased the relative levels of HSP30. In studies with a human neuroblastoma SK-N-SH cell 
line, it was determined the HSP27 degradation did not occur via the UPS and suggested that 
it could occur through the autophagy-lysosomal pathway (Chang et al., 2009). Nevertheless, 
we cannot exclude the possibility that some of the Xenopus HSP30 family members may be 
degraded by the UPS. In contrast to HSP30, MG132 inhibited the cycloheximide-associated 
decline in HSP70 levels, suggesting that it was degraded via the UPS. These latter results are 
in agreement with Qian et al. (2006) who found that HSP70 degradation in HEK-293 cells 
recovering from heat stress occurred via the UPS. Also, Kundrat and Regan (2010) identified 
6 lysine residues of human HSP70 that were targeted by ubiquitination for proteasomal 
degradation via the 26S proteasome.  
In Xenopus, the differences in the patterns of HSP30 and HSP70 degradation may be 
associated with their function. While the primary role of HSP70 occurs in protein refolding, 
HSP30 binds to stress-induced unfolded/damaged protein to prevent their aggregation. It is 
possible that HSP30 oligomers hold client proteins for an extended amount of time until the 
cellular machinery can recover sufficiently to either refold or degrade the unfolded protein. 
Our previous studies determined that HSP30 forms multimeric structures, which bind to 
unfolded protein, prevent their aggregation and maintain them in a folding-competent state 
(Fernando and Heikkila, 2000; Abdulle et al., 2002; Fernando et al., 2002). Furthermore, 
phosphorylation of HSP30 multimers, which is mediated by the p38/MAP kinase pathway, 
resulted in their breakdown into smaller units (Ohan et al., 1998; Fernando et al., 2003). A 
similar phenomenon was found with HSP27 and αB crystallin in which phosphorylation was 
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shown to favor small oligomeric structures (such as dimers), while dephosphorylation was 
associated with large oligomeric structure formation (Parcellier et al., 2005). In the present 
study, A6 cells that were pretreated with SB203580 to inhibit HSP30 phosphorylation prior 
to heat shock and recovery in the presence of cycloheximide resulted in enhanced stability of 
HSP30 compared to cycloheximide alone.  
Additionally, in cells recovering from heat shock, immunocytochemistry revealed the 
presence of large perinuclear HSP30-immunoreactive structures that were larger and greater 
in number with prolonged recovery time or treatment with SB203580. Previously, similar 
HSP30 structures were detected in A6 cells treated with proteasome inhibitors such as 
MG132 and curcumin and were suggested to be associated with aggresomes (Young and 
Heikkila, 2010; Khan and Heikkila, 2011). Also, in avian cells MG132-induced HSP25, an 
HSP30-like sHSP, associated with structures that were proposed to be aggresomes (Katoh et 
al., 2004). In the present study, during recovery from heat shock, a Proteostat aggresome 
assay revealed the presence of aggresome-like structures that increased in size and number in 
the presence of SB253080. Aggresomes are perinuclear microtubule-dependent inclusion 
bodies that arise from the coalescence of individual protein aggregates (Kopito, 2000; Bauer 
and Richter-Landsberg, 2006; Bolhuis and Richter-Landsberg, 2010; Shen et al., 2011; 
Driscoll and Chowdhury, 2012; Nakajima and Suzuki, 2013). This process is thought to 
occur when the capacity of the proteasome to degrade protein is exceeded or inhibited. The 
aggregates are transported along microtubules by dynein to a perinuclear microtubule-
organizing center to form aggresomes until they undergo proteolysis by 
autophagy/lysosomes. This process reduces the cytoxic effects of scattered cellular protein 
aggregates. Previously, formation of these aggresome-like structures were detected in 
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mammalian cells in response to various stressors and co-localized with HSP27 (Ito et al., 
2005; Mi et al., 2009; Bolhuis and Richter-Landsberg, 2010). 
Since the present study determined that Xenopus HSP30 was more stable during 
recovery from heat shock than HSP70, it is likely that the presence of HSP30 in 
multimeric/granular complexes and its association with aggresomes may delay its 
degradation by an as yet unknown mechanism. It is also possible that heat shock-induced 
large HSP30 granular complexes may bind to unfolded or misfolded protein and that during 
recovery from stress these complexes become associated with stress granules or aggresomes 
to minimize the potential toxic effects of aggregated protein on cell function. 
  
4.2 Proteasome inhibition induces cytosolic/nuclear and ER molecular chaperones in 
A6 cells 
The second part of this study examined the effect of proteasomal inhibitors on the 
accumulation of cytosolic/nuclear HSPs, HSP30 and HSP70, the endoplasmic reticulum HSP 
members, BiP and GRP94, and heme oxygenase-1 (HO-1), an enzyme that is induced by 
stressors such as oxidative stress or heavy metals. Treatment of Xenopus cells with 30 μM 
MG132, 5 μM withaferin A and 2.5 μM celastrol induced an inhibition of proteasome 
activity and the induction of HSP30, HSP70, BiP and GRP94 in a time-dependent manner. 
MG132-, withaferin A- or celastrol-induced inhibition of proteasomal activity was indicated 
by an increase in ubiquitinated protein and a decrease in proteasomal CT-like activity. 
Previously, our laboratory reported that MG132 and celastrol increased the relative level of 
ubiquitinated proteins in A6 cells in comparison to control cells and that celastrol decreased 
CT-like activity of the 26S proteasome by 50 % (Young and Heikkila, 2009; Walcott and 
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Heikkila, 2010). Additionally, Yang et al. (2006) demonstrated that 2.5 M celastrol 
treatment of human prostate cells also resulted in an increase in ubiquitinated protein and 
inhibition in CT-like activity of the proteasome. Furthermore, these results are similar to 
findings with human prostate cancer cells in which treatment with 5 to 20 μM withaferin A 
resulted in an increase in ubiquitinated protein in a dose-dependent manner and a 50% 
inhibition in CT-like activity after treatment with 20 μM withaferin A for 16 h (Yang et al., 
2007). In this latter study, it was suggested that withaferin A-induced proteasomal inhibition 
resulted from a direct interaction between withaferin A and the β5 subunit of the 20S 
proteasome, which possesses CT-like activity. Recently, Feng et al. (2013) also demonstrated 
that celastrol interacted with the β1 subunit of the human recombinant proteasome and 
decreased the CT-like activity in vitro. It is possible that celastrol and withaferin A may have 
a similar effect on the β1 and β5 subunits in Xenopus cells, respectively.  
The accumulation of HSP30 and HSP70 as well as their mRNAs in cells in which the 
proteasome is inhibited is likely the result of an activation of the heat shock response. HSP 
accumulation as a result of proteasome inhibition is a well-documented phenomenon in 
eukaryotic systems. For example, in previous studies from our laboratory proteasomal 
inhibition using MG132, lactacystin and celastrol induced HSP30 and HSP70 in Xenopus A6 
cells (Young and Heikkila, 2010; Walcott and Heikkila, 2010). Similarly, the induction of 
HSP accumulation by proteasomal inhibitors was described in yeast and mammalian cells 
(Lee and Goldberg, 1998; Bush et al., 1997; Pritts et al., 2002; Stangl et al., 2002; 
Westerheide et al., 2004; Awasthi and Wagner, 2005; Chow and Brown, 2007; Zhang and 
Sarge, 2007; Trott et al., 2008; Kalmar and Greensmith, 2009). Interestingly, MG132, 
celastrol and withaferin A have different modes of action within cells, but resulted in similar 
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levels of HSPs suggesting that multiple pathways might exist for proteasomal inhibitor-
induced HSP accumulation in A6 cells. 
There are at least two possible mechanisms by which proteasome inhibition can 
induce the accumulation of unfolded or damaged protein which could ultimately activate the 
heat shock response. Since the proteasome degrades 80 to 90 percent of total cellular protein, 
it is possible that inhibition of the proteasome by classical proteasome inhibitors such as 
MG132 may cause an increase in the concentration of misfolded or damaged proteins, which 
could ultimately activate HSF1 and result in the subsequent upregulation of hsp gene 
expression (Young and Heikkila, 2010; Walcott and Heikkila, 2010; Khan and Heikkila, 
2011). Additionally, in a chicken erythroblast cell line, HD6, the activities of HSF1, HSF2, 
and HSF3 were upregulated by MG132 (Kawazoe et al. 1998). Moreover, in mouse 
embryonic fibroblast cells, both MG132 and lactacystin, both of which are known 
proteasome inhibitors, induced hyperphosphorylation, trimerization, and HSE binding 
activity of HSF1 (Kim et al. 1999).  
Another possible mechanism for celastrol or withaferin A-induced damage of cellular 
protein leading to the activation of the heat shock response involves the direct effect of these 
proteasomal inhibitors on protein structure. For example, studies with yeast and mammalian 
cells demonstrated that celastrol interacts with cysteine residues on proteins through its thiol 
groups and renders proteins inactive (Trott et al., 2008). Additionally, previous studies also 
found that withaferin A bound to cysteine residues in the C-terminus of HSP90 and inhibited 
its chaperone activity by disrupting its ability to bind to client proteins (Yu et al., 2010; 
Grover et al., 2011; Gu et al., 2014). These findings suggest that both celastrol and withaferin 
A can modify various proteins via thiol reactivity and could ultimately contribute to an 
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increase in HSPs. More recently, it was determined that the -unsaturated carbonyl motif 
of withaferin A reacted with proteins by forming adducts with thiol groups in cysteine 
residues and that this motif was necessary but not sufficient for heat shock activation of 
green fluorescent protein controlled by a minimal consensus HSE-containing promoter in a 
reporter cell line (Ozorowski et al., 2012; Santagata et al., 2012). Since monomeric inactive 
HSF1 is normally bound to HSP90, binding of withaferin A to HSP90 might disrupt this 
complex allowing HSF1 to trimerize and activate hsp expression. 
Activation of the unfolded protein response by MG132, celastrol and withaferin A in 
A6 cells was suggested by the accumulation of bip mRNA and BiP and GRP94 protein. 
These results are in agreement with previously published results in other vertebrate systems, 
in which, proteasomal inhibitors induced the unfolded protein response (Choi et al., 2011; 
Park et al., 2011; Nakajima et al., 2011; Feng et al., 2013). For example, MG132 induced the 
enhanced accumulation of ER stress markers including bip, chop and atf4 mRNA in NRK-
53E renal tubule epithelial cells (Nakajima et al., 2011). More recently, Feng et al. (2013) 
demonstrated that celastrol induced the accumulation of ER stress-related proteins including 
pancreatic ER kinase (PERK), inositol-requiring enzyme 1 (IRE1), BiP and CHOP in HeLa 
cells. Additionally, a study by Choi et al. (2011) determined that treatment of mammalian 
Caki cells with 2-6 μM withaferin A induced ER stress as indicated by the enhanced 
accumulation of bip mRNA and encoded protein. While the mechanism responsible for 
MG132, celastrol and withaferin A induction of the ER chaperones in Xenopus cells is not 
known, it is possible that these chemicals may cause an increase in unfolded and/or 
misfolded proteins in the ER lumen resulting from the repression of proteasomal activity. As 
mentioned previously an increase in unfolded protein results in enhanced accumulation of 
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BiP and GRP94 in order to inhibit the production of protein aggregates and maintain client 
protein in a competent state for subsequent folding, oligomerization and translocation (Lee 
and Goldberg, 1998). Furthermore, it is also possible that MG132, celastrol and withaferin 
A-induced proteasomal inhibition may slightly increase the relative levels of HSP70 after 
they are induced since it cannot be degraded due to the inhibition of the proteasome. In these 
experiments, the relative levels of actin were not altered. It is possible that its relatively long 
half-life and abundance in the cell may mask an increase in its relative levels by proteasomal 
inhibition. 
Immunocytochemistry was employed to determine the localization of HSP30 and BiP 
in cells treated with MG132, celastrol or withaferin A. A6 cells exposed to MG132, celastrol 
or withaferin A accumulated HSP30 mainly in the cytoplasm in a granular pattern with a 
lesser amount of HSP30 staining in the nucleus. The punctate pattern of HSP30 accumulation 
may reflect the stress-induced formation of HSP30 multimeric structures that are associated 
with its cellular function in the prevention of toxic aggregates (Johnston et al., 1998; 
MacRae, 2000; Van Montfort et al., 2002; Heikkila, 2010). Cells treated with A23187, an 
inducer of the unfolded protein response, did not show any HSP30 accumulation. In 
comparison, cells treated with A23187, MG132, celastrol or withaferin A had an enhanced 
accumulation of BiP in a punctate pattern in the perinuclear region and occasionally at the 
periphery of the cell membrane. The enhanced accumulation and localization pattern of BiP 
in A6 cells is indicative of an unfolded protein response. For example treatment of cells with 
ER stressors such as thapsigargin, a Ca
2+-
ATPase inhibitor, or tunicamycin were reported to 
upregulate BiP in a punctate pattern with coalescence of BiP in the perinuclear region of 
mammalian cells (Kitiphongspattana et al., 2005; Sun et al., 2006). A similar response was 
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also reported with proteasome inhibitors, MG132 and/or lactacystin in mouse pancreatic β-
cell cytoplasm and dog MDCK cells (Bush et al., 1997; Kitiphongspattana et al., 2005; Haas 
et al., 2007).  
In some proteasome inhibited A6 cells, a co-localization of HSP30 with actin was 
observed which is in accord with the potential role of sHSPs in stabilization of the actin 
cytoskeleton (MacRae, 2000; Van Montfort et al., 2002; Doshi et al., 2009). Furthermore, 
cells treated with MG132 or withaferin A did not display a disruption in the F-actin 
cytoskeleton, which has been employed as a positive indicator of cellular health (Wiegent et 
al., 1987; Ohtsuka et al., 1993). In contrast, treatment of A6 cells with celastrol induced a 
rounded cell shape and disrupted actin cytoskeleton as indicated by F-actin localization to the 
cell periphery. The mechanism for the disruption of the actin cytoskeleton in A6 cells is 
unknown. It is possible that celastrol might inhibit nuclear factor kappaB (NF-κB), which is 
linked to decreased levels of cell adhesion molecules that are required for proper attachment 
of the cytoskeleton to the extracellular matrix (Collins et al., 1995; Tozawa et al., 1995).  
In an ancillary study, the effect of proteasomal inhibitors on the relative levels of HO-
1 was examined in A6 cells. As mentioned previously, HO-1 is a 32 kDa cytosolic protein, 
which functions as an enzyme that catalyzes the catabolism of heme into bilirubin via 
biliverdin (Uppu et al., 2010). It is induced in cells in response to oxidative stress (Keyse and 
Tyrrell, 1989; Turner et al., 1999). In the present study, treatment of A6 cells with withaferin 
A and celastrol enhanced the accumulation of HO-1 and HSP30 in a time- and concentration-
dependent manner. Immunocytochemical analysis utilizing laser scanning confocal 
microscopy showed that treatment of A6 cells with proteasome inhibitors resulted in HO-1 
accumulation primarily in the cytoplasm in a granular pattern. These results are in agreement 
 159 
with recent studies showing HO-1 induction in response to proteasome inhibition (Wu et al., 
2004; Kastle et al., 2012; Furfaro et al., 2014). For example, Kastle et al. (2012) 
demonstrated that treatment of human foreskin fibroblast and HT29 colon carcinoma cells 
with lactacystin induced HSP27, HSP70 and HO-1 accumulation. More specifically, 
proteasome inhibition by lactacystin induced the deacetylation of HDAC6 resulting in the 
subsequent phosphorylation of p38-MAPK and activation of the NRF-2, which is a 
transcriptional activator of HO-1. Previously, Wu et al. (2004) also showed enhanced 
accumulation of HO-1 in murine macrophages in response to MG132 through the activation 
of the p38-MAPK pathway. 
 
4.3 Proteasomal inhibition, sodium arsenite and cadmium chloride induce large 
HSP30 multimeric structure, stress granule and aggresome formation in A6 cells 
In the final part of this study, I attempted to identify the structures associated with the 
relatively large HSP30 staining foci induced by the proteasomal inhibitors, MG132, celastrol 
and withaferin A. Similar large HSP30 staining structures were reported in A6 cells exposed 
to sodium arsenite or cadmium chloride, which can also inhibit proteasome function 
(Woolfson and Heikkila, 2009; Young and Heikkila, 2009; Brunt et al., 2011). Although the 
identity of these HSP30 staining foci is unclear, it is known from studies with mammalian 
cells that proteasomal inhibitors can induce the formation of RNA stress granules containing 
stalled translational complexes or aggresome-like structures, which are proteinaceous 
inclusion bodies that form as a general cellular response to aggregated protein (Garcia-Mata, 
1999; Kopito, 2000; Kedersha et al., 2002; Anderson and Kedersha, 2009).  
 160 
RNA stress granules are RNA-protein complexes composed of stalled pre-initiated 
mRNA bound to 40S ribosomal subunit, RNA binding proteins such as TIA1 and various 
eukaryotic protein synthesis initiation factors such as eIF3, eIF4F, eIF4B, and PABP 
(Kedersha et al., 2007). In the current study, A6 cells treated with MG132 and withaferin A 
showed enhanced accumulation and co-localization of TIA1 and PABP, markers of stress 
granule formation (Kedersha et al., 2000; Anderson and Kedersha, 2002; Gilks et al., 2004; 
Kedersha and Anderson, 2007). Inhibition of the UPS using MG132, lactacystin or 
Bortezomib was reported to induce stress granule formation in HeLa cells (Mazroui et al., 
2007; Fournier et al., 2010). Furthermore, the MG132-induced formation of stress granules 
required phosphorylation of eIF2α (Mazroui et al., 2007). Sodium arsenite treatment in A6 
cells also resulted in an increase in the formation of stress granules. This was in accordance 
with previous literature reporting that sodium arsenite induced the formation of stress 
granules in HeLa cells (Kedersha et al., 2000). Additionally, Satoh et al. (2012) demonstrated 
that RNA-binding protein Nrd1 localized to PABP-positive stress granules in response to 
heat, arsenite treatment and oxidative stress. In the present study, no co-localization was 
observed between HSP30 and PABP1 in A6 cells treated with proteasome inhibitors. Studies 
examining the association of sHSPs with proteasomal inhibitor-induced formation of stress 
granules in other experimental systems are quite limited. While Mazroui et al. (2007) 
established that only HSP72 co-localized with stress granules in HeLa cells, Ma et al. (2009) 
did observe that HSP27 and HSP72 were co-immunoprecipitated with PABP1 and eIF4G in 
HeLa cells recovering from heat stress.  
The present study revealed that treatment of A6 cells with MG132 or withaferin A 
also induced the formation of aggresomes-like structures. Anti-vimentin and anti-γ-tubulin 
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antibodies were used as markers for the presence of aggresomes, along with the ProteoStat 
aggresome assay described previously. Vimentin and γ-tubulin have been extensively used as 
markers for detecting aggresomes in many cellular systems (Kopito, 2000; Liewluck et al., 
2007; Mi et al., 2009; Taylor et al., 2012; Xiong et al., 2013). More recently, Shen et al., 
2011 used the ProteoStat aggresome assay to show the presence of aggresomes in HeLa cells 
treated with MG132. In the present study, ProteoStat co-localized with both vimentin and -γ-
tubulin in cells treated with selected proteasome inhibitors. An increase in the appearance of 
aggresomes was detected using the ProteoStat assay and anti-vimentin and anti-γ-tubulin 
antibodies in cells treated with MG132, withaferin A, arsenite and cadmium in comparison to 
control. These results confirm previous mammalian studies demonstrating the formation of 
aggresomes in cells treated with proteasome inhibitors. For example, Taylor et al. (2012) 
showed the presence of aggresome formation in human embryonic kidney and neuroblastoma 
cells in response to MG132. More recently, prolonged exposure to MG132 treatment resulted 
in the formation of vimentin-caged aggresome-like inclusion bodies in rat mesencephalic 
dopaminergic cells (Xiong et al., 2013). Additionally, Song et al. (2008) demonstrated that 
cadmium treatment of HEK293 cells resulted in aggresome formation as determined by 
means of γ-tubulin, dynein, HDAC6 and ubiquitin co-localization. Also, arsenite-induced 
aggresome formation was reported in baby hamster kidney (BHK) cells (Heir et al., 2006). 
Recently, Jacobson et al. (2012) demonstrated that arsenite interfered with protein folding 
and induced the formation of protein aggregates.  
As mentioned previously, formation of aggresome-like structures that were detected 
in mammalian cells in response to various stressors co-localized with HSP27 (Ito et al., 2005; 
Mi et al., 2009; Bolhuis and Richter-Landsberg, 2010). In the present study, multimeric 
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HSP30 complexes were also shown to co-localize with aggresome-like structures as 
indicated by ProteoStat assay and the presence of vimentin and γ-tubulin in cells treated with 
MG132, withaferin A, sodium arsenite and cadmium chloride. Moreover, co-
immunoprecipitation experiments revealed that HSP30 associated with γ-tubulin and β-actin. 
Evidence for sHSP association with cytoskeletal proteins exists in a variety of systems 
especially as part of the aggresomes (Goldbaum et al., 2009; Richter-Landsberg and Leyk, 
2013). For example, Goldbaum et al. (2009) demonstrated that treatment of rat astrocytes 
with MG132 resulted in aggresome formation containing HSP25 (human HSP27 homolog), 
ubiquitinated protein and cytoskeletal proteins. Additionally, this latter study determined that 
HSP25 protected astrocyte morphology during MG132 treatment. More recently, Jacobson et 
al. (2012) demonstrated that arsenite-induced protein aggregates in yeast cells. Cadmium 
treatment of HEK293 cells also resulted in the formation of aggresomes containing HSP70, 
HSP40 and ubiquitinated protein (Song et al., 2008). In the current study, we also detected 
the presence of aggresome-like structures during recovery from heat shock that increased in 
size and number in the presence of SB253080 using a Proteostat aggresome assay. This 
suggests that formation of aggresomes is associated with the multimeric nature of sHSPs and 
not just limited to proteasome inhibition. To this effect, Zhang and Qian (2010) have shown 
that HSP70 is required for targeting proteins to aggresomes under stressful conditions; 
however, HSP70 is not a part of the aggresome complex. 
Taken together, these findings suggest a link between proteasome inhibition, HSP 
induction as well as aggresome and stress granule formation in Xenopus laevis A6 kidney 
cells as outlined in Figure 38. Under normal conditions, the association of HSF1 with HSP90 
and HDAC6 maintains it in a monomeric inactive state. Upon treatment of cells with   
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Figure 38. Model of stress-induced HSP30 induction, stress granule and aggresome 
formation in Xenopus A6 kidney epithelial cells. 1) HSF1 exists in cells in a monomeric 
inactive form, bound to HSP90 and HDAC6. 2) Proteasome inhibition of cells using MG132, 
celastrol or withaferin A results in an increase in ubiquitinated proteins. 3) Heat shock or 
chemical stress also causes an increase in unfolded proteins in cells. 4) An increase in 
unfolded ubiquitinated protein recruits HDAC6 and HSP90 to prevent its aggregation. 
HSP90 also binds unfolded proteins in stressed cells. 5) Once HSF1 is not bound to HSP90 
or HDAC6, it can trimerize and translocate to the nucleus resulting in an increase in HSPs, 
including HSP30. 6) Stress-induced HSP30s are then recruited towards unfolded protein 
complexes and keep them in a folding competent state. HSP30 forms multimeric complexes 
to bind unfolded protein in cells. 7) HDAC6 complexed with ubiquitinated proteins are 
transported along microtubule networks to stress granules, which contain RNA-binding 
proteins such as TIA1 and PABP. 8) Large multimeric HSP30s complexes also interact with 
cytoskeletal proteins such as vimentin or γ-tubulin as well as HDAC6, HSP90 and 
ubiquitinated protein complexes to form large aggresome-like structures. 
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MG132, celastrol or withaferin A, there is an increase in ubiquitinated and misfolded 
proteins. HDAC6 and HSP90 dissociate from HSF1 as they are recruited to bind 
ubiquitinated and misfolded proteins, respectively. This causes the trimerization, 
phosphorylation and binding of HSF1 to HSEs, resulting in stress-induced hsp gene 
expression. HDAC6 bound to ubiquitinated proteins can bind to PABP, TIA1 and G3BP 
resulting in the formation of stress granules. Additionally, stress-induced sHSPs, particularly, 
HSP30, forms multimeric complexes and binds misfolded and ubiquitinated proteins to 
prevent their aggregation. Over an extended period of time, HSP30 also binds cytoskeletal 
proteins such as tubulin, actin and vimentin, along with misfolded proteins. This results in 
the formation of aggresome-like structures or inclusion bodies, which are aggregates of 
cytoskeletal proteins along with misfolded proteins associated with large HSP30 granules. 
At present, there is significant evidence available in support of this model. Boyault et 
al. (2007) have shown that HDAC6 is part of the HSF1 and HSP90 complex. Upon 
proteasome inhibition, HDAC6 and HSP90 are recruited to bind polyubiquitinated proteins. 
Additionally, it was demonstrated that HDAC6 binds to polyubiquitinated chains on proteins 
by means of lysine 63 of ubiquitin (Olzmann and Chin, 2008). This causes monomeric HSF1 
to trimerize as it is no longer bound to HSP90 or HDAC6, resulting in stress-induced HSPs 
(Boyault et al., 2007). HDAC6 also binds tubulin and acts as a bridge between ubiquitinated 
proteins and the microtubule network by moving aggregated proteins towards the perinuclear 
region resulting in the formation of aggresomes (Kawaguchi et al., 2003).  
More recently, HDAC6 was determined to be a crucial element in the formation of 
stress granules (Kwon et al., 2007). HDAC6 interacted with G3BP and TIA1 as a result of 
proteasome inhibition with MG132 and directed the formation of stress granules through the 
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microtubule network. These findings taken together suggest a prominent role of HDAC6 in 
the pathway.  
 
4.4 Significance of this thesis 
 This study has provided significant insight into the detection and understanding of the 
effect of toxicological agents on protein unfolding and the triggering of both the heat shock 
and unfolded protein responses in Xenopus A6 kidney epithelial cells. For example, my 
findings that arsenite, cadmium and other proteasomal inhibitors induced HSPs, HO-1, as 
well as aggresome and stress granule formation suggest that their presence could be used as 
potential molecular biomarkers of toxicological stress in other aquatic and possibly terrestrial 
organisms. This study also indicates that sHSPs, such as Xenopus HSP30, which has a 
prolonged decay pattern, may be more useful as molecular biomarkers of recent cell stress 
events than HSP70. Finally, this thesis research produced basic information on the effects of 
proteasomal inhibition and sHSP accumulation, which may be of importance in our 
understanding of human protein misfolding diseases.   
 
4.5 Future directions 
In this thesis, I have examined the stress-induced accumulation of multimeric HSP30 
complexes and the formation of stress granules and aggresomes in Xenopus A6 kidney 
epithelial cells. Further studies examining the possible involvement of HSP30 and other 
HSPs, such as HSP70, in the formation of aggresomes should be conducted. In cos7 cells, the 
involvement of HSP70 with bcl-2-associated athanogene 3 (BAG3) was found to direct 
chaperone-mediated misfolded proteins to the aggresome (Gamerdinger et al., 2011). One 
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approach would be to create FLAG-tagged hsp30 and hsp70 gene constructs and after their 
transfection into A6 cells, one could study the role of these HSPs in aggresome formation. 
An alternative approach would be to overexpress these HSPs in A6 cells by transfecting 
FLAG-tagged hsp30 and hsp70 gene constructs and monitoring the association of these 
FLAG-tagged HSPs with aggresomes. Furthermore, it is possible to use RNAi or antisense 
morpholino oligonucleotides (Dirks et al., 2010; Bestman and Kline, 2014; Guo et al., 2014) 
to inhibit the synthesis of HSP30 or HSP70 in A6 cells and study their effect on the 
formation of aggresomes. Additionally, nocodazole, which has been shown to inhibit 
aggresome formation by inhibiting microtubule polymerization (Bauer and Richter-
Landsberg, 2006), could be used to study the involvement of HSP30 and HSP70 in the 
formation of aggresomes in Xenopus cells. Finally, it will be interesting to observe the 
formation of stress granules and aggresomes in response to proteasome inhibition in Xenopus 
embryos in various tissues during development. 
  An important approach to the study of stress-induced HSPs as well as aggresome and 
stress-granule formation is to examine the role of HDAC6 in Xenopus cells. Unfortunately, 
due to the lack of an available antibody against Xenopus HDAC6, I was not able to 
investigate the involvement of HDAC6 in the stress-induced formation of aggresomes and 
stress granules. Since, HDAC6 was found to play a prominent role in mammalian aggresome 
formation, future research into the role of HDAC6 in the current Xenopus model of protein 
aggregation would be highly beneficial. Finally, the mechanisms by which protein aggregates 
are cleared from Xenopus cells is not well understood and should be assessed. One possible 
pathway involves autophagy and lysosomes. For example in mammalian cells, it was 
determined that MG132- and celastrol-induced aggresomes were cleared through autophagy 
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(Wang et al., 2011; Lee et al., 2012; Williams et al., 2013). Studying the formation and 
clearance of aggresomes in cells recovering from proteasome inhibition in A6 cells could 
provide insight into how Xenopus cells deal with enhanced levels of aggregated protein. 
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